Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.7812733987302268,-1.9892708361893525,0.0,0.022238464768362283,0.021,13/19,13.75%,GRM7;GRIA2;GRM5;GRIA1;GRM1;GRM3;GRIK4;GRIA4;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7720882159873108,-1.865502867509749,0.0,0.10815980591885292,0.18,7/14,15.94%,SLC7A11;SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.745082893121783,-1.8382738763411322,0.0,0.10377950225235733,0.248,6/15,8.99%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH2;ALDH7A1;ALDH1L1
prerank,adenylate cyclase binding (GO:0008179),-0.8236659169618544,-1.8381796307466263,0.0,0.077834626689268,0.248,5/10,5.97%,ADCY5;ADCY2;AKAP12;AKAP6;CAP2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.7289064645626637,-1.8191555708288267,0.0,0.08147364819681818,0.299,7/15,15.94%,SLC1A3;SLC1A5;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,platelet-derived growth factor binding (GO:0048407),-0.80434663839965,-1.8147530509510674,0.0,0.07278043015100384,0.319,7/11,2.27%,COL1A2;COL3A1;COL1A1;PDGFRB;PDGFRA;COL5A1;COL6A1
prerank,retinoid binding (GO:0005501),-0.6781022762367451,-1.813338655711574,0.0,0.06426049884364426,0.325,7/22,8.27%,ALDH1A2;PTGDS;RBP1;ABCA4;RBP4;CYP26B1;CRABP2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.759070183563673,-1.8036014965553413,0.0022172949002217295,0.06229297233410572,0.354,5/13,9.04%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.7643566924172531,-1.8032174102396454,0.0,0.05559616192090571,0.355,6/13,8.99%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH2;ALDH7A1;ALDH1L1
prerank,metalloendopeptidase activity (GO:0004222),-0.5258028492561493,-1.7948504545007382,0.0,0.055393994059375146,0.376,22/76,12.48%,TRABD2B;ADAMTS12;ADAMTS2;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS10;ADAMTS5;ADAMTSL1;MMP14;ADAMTS17;ADAMTSL4;MMP16;ADAM19;ADAMTS15;ADAMTS1;ADAM33;MMP2;ADAMTS14;ADAM9;MMP11
prerank,pre-mRNA binding (GO:0036002),-0.621167384693382,-1.7738915354678293,0.0,0.06745055016519799,0.468,9/28,15.57%,CELF2;DDX5;CELF4;U2AF2;RBM4;CELF1;HNRNPU;HNRNPA1;RNPC3
prerank,BMP receptor binding (GO:0070700),-0.7590758380490807,-1.7460510652830492,0.0045351473922902496,0.08870114924653592,0.584,5/12,9.04%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,sialyltransferase activity (GO:0008373),0.7399116463913287,1.7094253935275832,0.01206896551724138,1.0,0.898,6/20,7.31%,ST3GAL6;ST6GALNAC3;ST6GAL1;ST3GAL1;ST8SIA4;ST6GALNAC2
prerank,amino acid:sodium symporter activity (GO:0005283),-0.7549127747868098,-1.7086682855458257,0.00641025641025641,0.12728799589443726,0.753,6/11,7.50%,SLC6A13;SLC1A3;SLC6A1;SLC6A12;SLC6A15;SLC1A2
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.7246640536749076,-1.7033647229219897,0.002173913043478261,0.1275823611873252,0.782,5/12,8.72%,SULF1;SULF2;ARSI;ARSB;ARSG
prerank,death receptor activity (GO:0005035),0.8397676749408381,1.696997802209574,0.02010968921389397,1.0,0.932,6/11,7.31%,TNFRSF19;FAS;TNFRSF11A;TNFRSF1B;TNFRSF25;TNFRSF1A
prerank,phospholipid transfer activity (GO:0120014),0.7333681797938472,1.6959113374850603,0.010084033613445379,1.0,0.936,10/21,13.86%,CERT1;PLTP;PRELID2;PITPNM2;GLTP;ABCA3;PLEKHA8;PITPNC1;C2CD2L;PITPNB
prerank,leak channel activity (GO:0022840),-0.6658031933769092,-1.6848096991235566,0.009345794392523364,0.14744776034295962,0.857,3/18,2.75%,KCNK2;NALCN;KCNK5
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5882547233459932,-1.681502849901621,0.007246376811594203,0.143539181686702,0.865,13/29,13.75%,GRIA2;GABRG2;GABRA2;GRIK4;GRIA4;GABRB1;GRIK2;GRIK5;GABRB3;GRID2;GRIK1;GABRG3;GRIN2D
prerank,phosphatidylinositol binding (GO:0035091),0.5792525906183662,1.675343647184394,0.0,1.0,0.964,34/91,14.14%,EPB41;MCF2L;PARD3;HIP1;HIP1R;SCARB1;PITPNM2;DENND1B;MTM1;ESYT2;FCHO2;WDFY3;CCDC88A;EEA1;GRB7;ITPR3;PIGU;PLEKHF2;MYO1E;SNX24;MREG;PITPNC1;SH3YL1;PIGK;AIDA;ANKFY1;PICALM;PARD3B;SNX11;C2CD2L;ESYT1;EXOC8;PITPNB;SNX13
prerank,anion transmembrane transporter activity (GO:0008509),0.8146505392237007,1.672561952884111,0.0210896309314587,0.8731518621999687,0.966,3/12,0.92%,SLCO2B1;ABCG2;SLC39A8
prerank,cadherin binding (GO:0045296),0.5121767185071201,1.6679271379977416,0.0,0.7700189954540007,0.971,86/315,14.47%,PTPRB;MRTFB;TJP1;DOCK9;FNBP1L;CLINT1;PKP4;BMPR2;KDR;ITGA6;EHD4;SPTBN1;EPN2;F11R;PPFIBP1;FLNB;PTPRM;CD2AP;LRRFIP1;TJP2;WASF2;IQGAP1;MYH9;DAB2IP;FASN;PTPRJ;SLC3A2;BSG;ESYT2;NCK1;COBLL1;STK24;PROM1;SWAP70;NUMB;TMOD3;PKN2;PAK2;TES;CDH2;PDLIM1;LASP1;CTNNA1;RPL34;TAGLN2;CHMP2B;ACVR1;UBAP2;SH3GLB1;FMNL2;UNC45A;HNRNPK;TBC1D2;TRIM25;CDH15;RPL15;PSEN1;SLK;RPL14;CHMP4B;PTPN1;CDH23;GAPVD1;SERBP1;TWF2;SPTAN1;FSCN1;SFN;CBL;STK38;PICALM;RAB11B;RPL6;RACK1;DBNL;HSP90AB1;LIMA1;CAPZA1;CAST;CDH5;TMPO;RARS1;APC;ERC1;RPL29;CNN3
prerank,phosphatidylcholine transporter activity (GO:0008525),0.7366708966084623,1.666001587677797,0.01794453507340946,0.6742101803514291,0.975,8/17,13.86%,ATP8B1;PLTP;ATP10A;PITPNM2;ABCA3;PITPNC1;ABCG1;PITPNB
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.5120370502646608,1.6645400757442548,0.0,0.5988760638837405,0.976,39/254,8.59%,MECOM;ERG;LEF1;ELK3;FOXO1;ESR1;MEF2C;ZBTB16;SMAD1;ZIC3;NFATC1;IRF2;HHEX;STAT3;NR3C1;HIF1A;KLF7;RREB1;SOX17;SOX18;TCF12;FOSL2;GTF2I;MAFF;SOX9;FOXF1;ELK4;FOXF2;HOXA10;TCF4;ATMIN;KLF10;NR1I3;HOXD8;TCF3;NFKB1;NEUROD1;NRL;CREB1
prerank,glycerophospholipid flippase activity (GO:0140333),0.7986255415083937,1.6540859402119834,0.023593466424682397,0.5984620751765071,0.988,6/11,8.15%,ATP8B1;ATP8A1;ATP10A;ATP11C;ABCA3;ATP11A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7690588283518036,1.6473984728804594,0.014109347442680775,0.5257807123211422,0.994,4/16,5.16%,PTPRB;PTPRG;PTPRM;PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7690588283518036,1.6473984728804594,0.014109347442680775,0.5257807123211422,0.994,4/16,5.16%,PTPRB;PTPRG;PTPRM;PTPRK
prerank,pyridoxal phosphate binding (GO:0030170),-0.6282964743391802,-1.637301797063121,0.012437810945273632,0.2112654152994417,0.957,9/20,22.96%,PYGB;ABAT;PYGM;ACCS;OAT;CBS;PDXK;CTH;PNPO
prerank,estrogen receptor binding (GO:0030331),0.6467263010205195,1.633830861463214,0.01889763779527559,0.5552416541413471,0.996,9/32,11.94%,LEF1;TACC1;ESR1;DDX54;NCOA1;NRIP1;CNOT1;MMS19;DCAF1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.8046411304785247,1.6160762899961358,0.03505535055350553,0.6144866226749544,0.998,1/10,0.03%,MECOM
prerank,poly(U) RNA binding (GO:0008266),-0.6297520335839429,-1.6056278311541996,0.026004728132387706,0.2710172499295868,0.99,5/20,6.19%,RBMS3;HNRNPH1;ATXN1;DAZAP1;RBMS1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.6764743435705277,-1.5941169174890797,0.024943310657596373,0.284205451656917,0.991,5/14,5.64%,TIMP3;COL4A3;TIMP2;RECK;NGF
prerank,voltage-gated calcium channel activity (GO:0005245),-0.5232466694809557,-1.5823263416574331,0.0028169014084507044,0.2980459698614373,0.993,7/37,5.58%,CACNA1C;CACNA2D3;CACNA2D1;CACNA1D;CACNB2;CACNA1G;ITGAV
prerank,ligand-gated channel activity (GO:0022834),-0.5589244262328739,-1.5744430997426742,0.023076923076923078,0.30551414693678663,0.995,14/29,13.75%,GRIN3A;GRIA2;GRIA3;GRIA1;ANXA6;GRIK4;GRIA4;GRIN2A;GABRB1;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,ligand-gated ion channel activity (GO:0015276),-0.5551184867763239,-1.5656279327431106,0.028720626631853787,0.31441697192128737,0.995,14/30,13.75%,GRIN3A;GRIA2;GRIA3;GRIA1;ANXA6;GRIK4;GRIA4;GRIN2A;GABRB1;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,calcium channel activity (GO:0005262),-0.4415949036260627,-1.5620027916610115,0.007462686567164179,0.31002002070361173,0.997,19/84,10.29%,SLC24A3;CACNA1C;CACNA2D3;CACNA2D1;CACNA1D;PKD1;P2RX4;MCU;CACNB2;ITGAV;TRPC3;ANXA2;TRPC6;ANXA6;TRPC1;CACNB1;RYR2;SLC24A2;TRPC4
prerank,metallopeptidase activity (GO:0008237),-0.4244628365862778,-1.557996444903522,0.0,0.30708455800403295,0.998,21/113,9.27%,TRABD2B;ADAMTS12;ADAMTS2;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;PAPPA;ADAMTS10;ADAMTS5;ADAMTSL1;MMP14;ADAMTS17;ADAMTSL4;MMP16;ADAM19;ADAMTS15;ADAMTS1;ADAM33;MMP2;ADAM12
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.7536098099194156,1.5551320484327162,0.046125461254612546,0.9819339005623551,1.0,4/10,8.27%,CASP4;CASP8;CASP7;CASP1
prerank,solute:anion antiporter activity (GO:0140323),-0.6475522371959346,-1.5536743351374651,0.04018912529550828,0.3054756387726856,0.999,6/14,14.48%,SLC7A11;SLC26A7;SLC26A2;SLC4A3;SLC4A2;SLC26A6
prerank,protein phosphatase 2A binding (GO:0051721),0.6570143925816977,1.5520825598900077,0.036243822075782535,0.9387276734257287,1.0,4/23,2.51%,FOXO1;CTTNBP2NL;DAB2IP;MFHAS1
prerank,phospholipase inhibitor activity (GO:0004859),-0.6920855020373302,-1.5510380649994266,0.02262443438914027,0.30056918028707835,0.999,6/10,18.11%,ANXA5;ANXA1;ANXA2;ANXA4;SNCA;ANGPTL3
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.619174796432766,1.5454871932048746,0.02276176024279211,0.9316608861932558,1.0,10/35,7.46%,PEAK1;LYN;PTK2B;YES1;FYN;SRMS;DYRK1A;BMX;LCK;PTK2
prerank,alkali metal ion binding (GO:0031420),-0.6542608927239246,-1.5442572108525068,0.04072398190045249,0.30508627844677483,1.0,2/13,2.18%,ATP1A2;HDAC4
prerank,SH3 domain binding (GO:0017124),0.5563159734237599,1.5372785509737574,0.024759284731774415,0.9357703329194689,1.0,13/62,6.17%,SHANK3;ABI3;CD2AP;ELMO1;WASF2;PTPN12;DAB2IP;AFAP1L1;AFAP1L2;ARHGAP27;EVL;SKAP1;ADAM15
prerank,growth factor receptor binding (GO:0070851),0.5256621604646486,1.5326082879358702,0.013192612137203167,0.9171229827575785,1.0,20/95,8.58%,IL1R1;IL6ST;ERN1;PDGFB;VEGFC;HIP1;IL6R;PDGFD;PTPRJ;FYN;FGF23;SDCBP;VEGFD;IL27RA;CCDC88A;PDGFC;TGFA;ERAP1;ITGA5;PSEN1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.4743172759140559,-1.5302648689397702,0.007017543859649123,0.32534585144883266,1.0,10/55,4.85%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC22A4;SLC38A11;SLC16A11
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.7237842559725569,1.5295985741219167,0.043875685557586835,0.889300036447588,1.0,9/12,22.17%,CNOT6;PAN3;CNOT6L;CNOT1;CNOT2;CNOT7;PAN2;TOE1;NOCT
prerank,actin monomer binding (GO:0003785),0.6627712559033189,1.5269353061430637,0.04530201342281879,0.8636632410301808,1.0,8/22,13.49%,NOS3;MTSS1;TMSB4X;MRTFA;TWF2;ABL2;PFN4;LIMA1
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5775839153596193,-1.5255042240268921,0.0413625304136253,0.32608281803766326,1.0,6/23,10.00%,RBMS3;HNRNPH1;ATXN1;DAZAP1;RBMS1;U2AF2
prerank,ion channel activity (GO:0005216),-0.4279107095868677,-1.5212323535398224,0.0041841004184100415,0.3253554784898579,1.0,23/80,13.75%,TRPM3;NALCN;PIEZO2;GRIN3A;GRIA2;ABCC9;GRIA3;GRIA1;TRPC6;ANXA6;TRPC1;CALHM5;GRIK4;GRIA4;UNC80;GRIN2A;GABRB1;GRIK2;GRIK5;TMEM63A;GRID2;GRIK1;GRIN2D
prerank,ligand-gated anion channel activity (GO:0099095),-0.607390287822276,-1.5178868057627388,0.04640371229698376,0.3226207777392616,1.0,10/17,22.93%,GLRB;GABRG2;GABRA2;GABRB1;GABRB3;GABRG3;CFTR;GABRA1;GABRA5;GABRA3
prerank,cytokine receptor activity (GO:0004896),0.5261246833292401,1.5173401633184136,0.02099737532808399,0.882198106865456,1.0,12/83,6.17%,IL1R1;IL6ST;LIFR;IL6R;FZD4;OSMR;GHR;CSF2RB;IL27RA;CX3CR1;IFNAR1;IFNAR2
prerank,gap junction channel activity (GO:0005243),-0.5581129426721908,-1.5165280910335641,0.0425531914893617,0.31550821890113995,1.0,3/22,3.58%,GJB6;GJA1;GJB2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.5225736330644083,-1.509970975235755,0.036931818181818184,0.3206198494909753,1.0,10/29,15.94%,SLC13A3;SLC26A7;SLC1A5;SLC26A2;SLC25A12;SLC25A13;SLC19A1;SLC26A6;SLC1A1;SLC25A18
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.6338655536577653,1.5073083100057318,0.03535353535353535,0.9055513711347898,1.0,6/25,4.08%,NOS3;FMO2;FMO4;FMO1;CH25H;CYP26A1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6838541148593513,-1.5045509526521321,0.05399568034557235,0.32317127277018454,1.0,4/10,8.66%,CACNA1C;CACNA1D;CACNB2;CACNB1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.7180874229409774,1.504039501593049,0.054673721340388004,0.8873901938073537,1.0,8/13,7.98%,IL1R1;ERN1;PDGFB;PDGFD;PTPRJ;VEGFD;PDGFC;ITGA5
prerank,wide pore channel activity (GO:0022829),-0.5511001259913938,-1.4999225729196521,0.04106280193236715,0.32439277438733144,1.0,3/23,3.58%,GJB6;GJA1;GJB2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6471812621522198,-1.499287750822366,0.046610169491525424,0.31658925538293525,1.0,8/12,22.93%,GABRG2;GABRA2;GABRB1;GABRB3;GABRG3;GABRA1;GABRA5;GABRA3
prerank,protein kinase C activity (GO:0004697),0.6999050099243517,1.4991602566618172,0.05263157894736842,0.8822927328556807,1.0,4/14,4.32%,PRKCH;PRKD1;PRKD3;PKN1
prerank,cation channel activity (GO:0005261),-0.42261716664230675,-1.4963198880535815,0.008368200836820083,0.3146169045116217,1.0,22/94,10.14%,SLC24A3;TRPM3;NALCN;PIEZO2;CACNA1D;KCNK5;PKD1;MCU;ANO1;ABCC9;CACNB2;TRPC3;ANXA2;TRPC6;ANXA6;KCNQ4;TRPC1;CALHM5;RYR2;SLC24A2;UNC80;TMEM38A
prerank,Hsp90 protein binding (GO:0051879),0.5910793688019235,1.494251445683525,0.04090909090909091,0.8757351517331047,1.0,7/33,6.74%,KDR;ERN1;AHR;NR3C1;HIF1A;UNC45B;UNC45A
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5837031068202546,-1.491903257341627,0.06323185011709602,0.31687152191475065,1.0,11/17,13.75%,GRIN3A;GRIA2;GRIA3;GRIA1;GRIK4;GRIA4;GRIN2A;GRIK2;GRIK5;GRIK1;GRIN2D
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5995563465200953,1.491573363623902,0.05799373040752351,0.8578737681859483,1.0,10/29,15.49%,GCH1;NFATC1;PTPRJ;PPM1D;DUSP16;MAPKAPK3;TNIP1;DUSP7;DUSP2;ACE
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6794070376555322,-1.4913893758665107,0.046153846153846156,0.3099907210135349,1.0,3/10,2.76%,SLC6A13;SLC6A1;SLC6A12
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5871886902074305,-1.4913024241318804,0.05034324942791762,0.3023420369189618,1.0,5/18,10.97%,ALDH1A1;ALDH1A2;AKR1B1;ALDH2;FAR1
prerank,fatty acid synthase activity (GO:0004312),0.742367879599171,1.4804954392308032,0.07647058823529412,0.8939580146506111,1.0,2/10,3.86%,ELOVL7;ELOVL5
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.6762628329765028,1.476642157669825,0.0944055944055944,0.8839250311870579,1.0,2/15,6.32%,PLA2G4A;PLA2G2D
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.5562788555675837,-1.4758076231257617,0.05063291139240506,0.32844881113539065,1.0,4/22,3.91%,RBMS3;CPEB1;CPEB2;CPEB3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.7066223064812371,1.473128909879277,0.08872458410351201,0.8739330160641,1.0,4/11,8.27%,CASP4;CASP8;CASP7;CASP1
prerank,potassium ion leak channel activity (GO:0022841),-0.604279950126881,-1.4709321280530787,0.07936507936507936,0.3314830901024391,1.0,2/15,2.75%,KCNK2;KCNK5
prerank,GTPase activator activity (GO:0005096),0.4477706861487358,1.4709048428053313,0.003236245954692557,0.8577514822908887,1.0,68/313,10.32%,CHN2;FGD5;TBC1D8;ARHGAP31;RGS3;DOCK9;GNAQ;PREX2;RAPGEF5;DENND5B;RALGAPA2;TBC1D30;ARAP3;ARHGEF15;RASGRF2;RIN3;CYTH1;DOCK1;ELMO1;TBC1D4;IQGAP1;FGD6;ARHGEF2;BCR;SRGAP2;DENND4C;DENND1B;SPATA13;DOCK4;RALGAPA1;ARHGAP27;SGSM1;RASGRP3;PLCB1;TBC1D22A;ADRB1;TBC1D15;KALRN;ARHGAP8;PREX1;SIPA1L3;DENND2D;ARHGAP17;HERC2;RAP1GDS1;MYCBP2;CCDC88A;OPHN1;RAPGEF2;PGAM5;TBC1D12;SMAP1;ARRB1;RASA1;RAP1A;TBC1D2;BNIP2;RASA4;EIF2B5;ARHGEF7;LLGL1;CYTH2;ARHGAP28;NPRL2;GAPVD1;OCRL;RGL2;LARS1
prerank,FMN binding (GO:0010181),0.7195283201962492,1.4678967875792495,0.08303249097472924,0.8484792036068162,1.0,1/11,0.31%,NOS3
prerank,1-phosphatidylinositol binding (GO:0005545),0.6806260252864734,1.4632919353060578,0.07259528130671507,0.8461515187142106,1.0,5/15,11.71%,EPB41;SCARB1;WDFY3;EEA1;PICALM
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.5854704413386934,-1.4595442586547223,0.06334841628959276,0.3488335927037293,1.0,6/16,15.94%,SLC13A3;SLC1A5;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,actin binding (GO:0003779),0.46615813322937855,1.4590199608768029,0.011961722488038277,0.8446573958344684,1.0,20/170,4.28%,MYRIP;FLII;NOS3;PARVB;ABLIM1;SLC6A2;UTRN;LCP1;EPS8;FLNB;MYH9;KLHL2;MTSS1;ACTN4;SHROOM2;SSH2;TMSB4X;SORBS1;PDLIM1;MRTFA
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4680908592217824,1.4541492360813078,0.019161676646706587,0.8456766493147371,1.0,26/147,6.12%,FGD5;DOCK9;PREX2;RAPGEF5;DENND5B;ARHGEF15;RASGRF2;RIN3;CYTH1;DOCK1;ELMO1;FGD6;ARHGEF2;BCR;DENND4C;DENND1B;SPATA13;DOCK4;ADRB1;KALRN;PREX1;DENND2D;HERC2;MYCBP2;CCDC88A;RAPGEF2
prerank,C2H2 zinc finger domain binding (GO:0070742),0.7241182647704508,1.4541334102372898,0.09467455621301775,0.8216847861167207,1.0,2/11,2.03%,LEF1;GATA2
prerank,CARD domain binding (GO:0050700),0.6675748348337491,1.4498428212862469,0.08922558922558922,0.821353595150934,1.0,10/14,20.06%,NOD1;CASP4;CARD10;CASP1;CARD16;RIPK2;IRGM;CARD9;BCL10;CARD19
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.4582395981799431,-1.4497960205976963,0.031746031746031744,0.36282239058548094,1.0,9/47,3.68%,SLC7A11;SLC7A2;SLC6A13;SLC47A1;PDPN;SLC6A1;SLC1A5;SLC22A4;SLC38A11
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.6289122050870943,1.4464097750425384,0.09395973154362416,0.8159650286265131,1.0,8/18,16.68%,RPS6KA3;RPS6KA1;SERPINB9;XIAP;GAS6;TNFAIP8;BIRC3;BIRC2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.567941519448022,-1.4454598613545864,0.06046511627906977,0.3640144662336473,1.0,11/19,22.93%,GABRG2;GABRA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1;GABRG3;GABRA1;GABRA5;GABRA3
prerank,hexose transmembrane transporter activity (GO:0015149),0.6943313160791355,1.4429904054072435,0.09945750452079566,0.8127164833852869,1.0,3/12,6.85%,SLC2A1;MFSD4A;PPBP
prerank,FAD binding (GO:0071949),-0.5180992290793901,-1.4388504066066055,0.061224489795918366,0.3720547895189148,1.0,6/24,10.64%,MICAL3;MICAL2;DDO;PRODH;CRY2;AIFM1
prerank,antiporter activity (GO:0015297),0.6316485735600869,1.4375815163744774,0.07939189189189189,0.8184493051432663,1.0,6/20,10.18%,SLC25A16;SLC35E4;CLCN3;ATP1A3;SLC25A30;SLC35D2
prerank,TBP-class protein binding (GO:0017025),0.6190974497032369,1.436276919079976,0.08818635607321132,0.8048188861840346,1.0,6/21,12.88%,ESR1;AHR;HHEX;TAF1B;YEATS2;GTF2A2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.6848698837539814,1.4355548502322604,0.102803738317757,0.7887272461067304,1.0,1/12,0.26%,ENTPD1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.701333589309894,1.4277987201651068,0.10905730129390019,0.8061424672223034,1.0,9/12,14.62%,VEGFC;DAB2IP;VEGFD;GREM1;CCDC88A;ITGA5;ITGB3;CDH5;PGF
prerank,alanine transmembrane transporter activity (GO:0022858),0.6837342930227244,1.4216950414195377,0.09444444444444444,0.8151456900713049,1.0,3/12,4.80%,SLC38A5;SLC3A2;SLC6A6
prerank,peptidase inhibitor activity (GO:0030414),-0.480186192722358,-1.416885513379196,0.05851063829787234,0.41739060518337223,1.0,7/33,6.42%,GPC3;TIMP2;TFPI;ITIH2;RENBP;RECK;SERPIND1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.5995507397961429,1.4165617465681575,0.09983079526226735,0.8214363928923806,1.0,6/24,9.21%,CERT1;PLA2G4A;DAB2IP;PLEKHA5;SNX3;PLEKHA8
prerank,protein kinase C binding (GO:0005080),0.5467485413115675,1.4089646124130815,0.07153502235469449,0.8405847505642797,1.0,12/43,10.19%,NELL2;HDAC9;ADCY4;CAVIN2;PRKD2;HDAC7;TIRAP;PKN1;CCDC88A;TRPV4;HINT1;TWF2
prerank,glutamate receptor binding (GO:0035254),0.6412328679184588,1.4054033651789894,0.10847457627118644,0.8401522823611293,1.0,3/17,3.95%,SHANK3;HIP1;HOMER2
prerank,endopeptidase inhibitor activity (GO:0004866),-0.4080199735069631,-1.4039687927313016,0.03968253968253968,0.4420316055756859,1.0,18/82,12.41%,TIMP3;SERPING1;COL4A3;TIMP2;TFPI;SERPINH1;ITIH2;RENBP;RECK;SERPINE2;NGF;SERPIND1;ANXA2;SERPINF1;BIN1;SERPINE1;CST3;SPOCK3
prerank,NAD binding (GO:0051287),-0.49790742536663984,-1.4037914536588092,0.08072916666666667,0.43356754548856224,1.0,6/26,7.60%,ALDH1A1;ME1;CRYL1;SIRT2;ALDH2;BDH2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5001182205715102,-1.4013938669276826,0.06807511737089202,0.4312846990031569,1.0,12/28,22.93%,GABRG2;GABRA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1;GABRG3;CHRNA7;GABRA1;GABRA5;GABRA3
prerank,protein phosphatase binding (GO:0019903),0.4649196783968974,1.3986770110075482,0.04203821656050955,0.8554662646269606,1.0,27/117,10.15%,FOXO1;PPP1R16B;CTTNBP2NL;IQGAP1;DAB2IP;KCNQ1;STAT3;MFHAS1;PXN;FLT4;PPP1R9B;JAK3;CEACAM1;ATP2B4;PPP3CB;SKAP1;CDKN1B;LCK;JAK1;PTK2;SNX3;SHOC2;ANAPC7;FBXL2;ANK1;SMG7;AP3B1
prerank,GABA receptor activity (GO:0016917),-0.5410285373868996,-1.3963915159145304,0.08108108108108109,0.4351762321338345,1.0,11/21,23.01%,GPR156;GABRG2;GABRA2;GABBR1;GABRB1;GABRB3;GABRG3;GABRA1;GABRA5;GABRA3;GABBR2
prerank,GTPase regulator activity (GO:0030695),0.43720579735283766,1.3952384533296254,0.017201834862385322,0.8542863968113458,1.0,44/212,10.32%,CHN2;TBC1D8;ARHGAP31;RGS3;GNAQ;PREX2;RALGAPA2;TBC1D30;ARAP3;DOCK1;TBC1D4;SH3BP4;IQGAP1;BCR;SRGAP2;RALGAPA1;ARHGAP27;SGSM1;RASGRP3;PLCB1;TBC1D22A;TBC1D15;ARHGAP8;PREX1;SIPA1L3;ARHGAP17;RAP1GDS1;CCDC88A;OPHN1;RAPGEF2;PGAM5;TBC1D12;SMAP1;ARRB1;RASA1;TBC1D2;BNIP2;RASA4;LLGL1;ARHGAP28;NPRL2;OCRL;RGS12;LARS1
prerank,calcium channel regulator activity (GO:0005246),0.5527828948968545,1.3939713512302185,0.08256880733944955,0.8429756339172921,1.0,4/37,8.74%,PRKG1;FKBP1A;SGK3;MCUB
prerank,protein kinase binding (GO:0019901),0.4142390378390101,1.3936190018117398,0.003131524008350731,0.8279045524541943,1.0,113/479,14.29%,NELL2;FRMD5;HDAC9;BMPR2;CAV1;ESR1;UTRN;SLC12A7;ADCY4;ACVRL1;GCH1;CAVIN2;SMAD1;PLCG1;NEDD9;TJP2;IQGAP1;DAB2IP;PRKD2;KCNQ1;ADAM10;STAT3;NR3C1;HDAC7;TRIM14;HIF1A;MSN;PTPRJ;SIK1;CCNK;TAOK2;PRKAR2B;PLCG2;CAV2;PPP1R12A;PAK2;SOX9;TIRAP;PKN1;RPS19;IKBKB;CEACAM1;GHR;PTPRK;TRIM68;TCF7L2;LRBA;CCDC88A;AURKA;DUSP22;RPS7;SKAP1;IFNAR2;ACVR1;RAC1;SASH1;CDKN1B;TRIB3;GNAT1;HNRNPA0;PPM1D;LCK;PTK2;AP2A1;GRB7;TCF3;TRPV4;RHOBTB1;DUSP16;POLA1;RPTOR;NEK6;ARHGEF7;LLGL1;MAP3K11;CRK;HINT1;RELB;PTPN1;RICTOR;MAP2K3;BCL2L1;MAPKAPK3;SPAG9;MAD2L2;TWF2;TNIP1;PRKAB1;EPHA4;PICK1;MAP3K13;STK38;IRAK4;PEBP1;RHOB;RELA;ADIPOR1;GSTP1;CEP68;ZFP36;RACK1;MYH6;WARS1;DUSP7;TRIB1;CDC25C;GSKIP;RPS6;CDH5;NPM1;TRAF6;BCL2L14;APC
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.4353509704800019,-1.3893984520171785,0.046153846153846156,0.44436107180069356,1.0,11/48,9.98%,TRPM3;NALCN;PIEZO2;SLC41A1;SLC12A2;ABCC9;TRPC6;TRPC1;CALHM5;ATP6V1B2;UNC80
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.6648629013217489,1.3893671734277813,0.09507042253521127,0.8325556425231301,1.0,4/12,2.87%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.580345727839588,-1.3884646280660766,0.11946902654867257,0.43818930364761877,1.0,11/14,38.90%,ALDH4A1;ALDH1L1;MTHFD1;NOXRED1;AASS;BLVRB;PYCR1;PYCR2;MTHFR;CRYM;ALDH1L2
prerank,retinoic acid receptor binding (GO:0042974),0.6307510839035739,1.3818639567911426,0.12542372881355932,0.8530014395546638,1.0,6/17,14.92%,TACC1;ACTN4;NRIP1;CNOT1;ASXL1;SNW1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.644678717790193,1.3758867855160832,0.12746858168761221,0.8634710877811629,1.0,7/14,19.59%,NOD1;MAL;CASP1;RACK1;APAF1;CASP8AP2;CTSH
prerank,low-density lipoprotein particle binding (GO:0030169),0.6236427303091131,1.3744670630613502,0.13333333333333333,0.8541231012657148,1.0,4/16,5.30%,PLTP;SCARB1;STAB1;SCARF1
prerank,lipoprotein particle binding (GO:0071813),0.5972077639865602,1.3725417335589787,0.13389830508474576,0.847571876333391,1.0,5/20,8.24%,PLTP;SCARB1;STAB1;SCARF1;LPL
prerank,cytokine receptor binding (GO:0005126),0.47334006795858635,1.3706618552071477,0.06613756613756613,0.8407933220177335,1.0,17/83,9.61%,IL6ST;LIFR;KITLG;VEGFC;IL6R;SOCS2;OSMR;PXDN;FKBP1A;SDCBP;VEGFD;IL27RA;USP15;JAK1;ERAP1;CSF1;IL23A
prerank,GTPase activity (GO:0003924),0.4351415584689236,1.370064359289928,0.03882352941176471,0.8291278672951893,1.0,52/192,17.98%,DNM3;RAB27A;GNAQ;GCH1;RAB11A;GBP5;GBP4;RASD2;GNB1;RAP1B;GPN3;RHOJ;RALB;GBP7;GNAI2;KRAS;NRAS;RAC1;GNAT1;RAP1A;RHOBTB1;RAB2A;GNA12;RAB38;ARL8B;DRG2;RNF112;RAB43;RAB11B;RHOB;HBS1L;GNA13;RAB31;RAB5A;RAB7A;ATL1;GBP3;RAB5B;NKIRAS1;RAB18;RAB32;GNAI3;RAB6A;IRGM;RHEB;MFN1;RHOA;RAB8B;RHOT1;EEF2;RND1;RAB1A
prerank,semaphorin receptor activity (GO:0017154),0.6775877003616334,1.3685026421285629,0.1275797373358349,0.8221644419982048,1.0,3/11,2.82%,NRP2;PLXNA4;PLXND1
prerank,potassium ion antiporter activity (GO:0022821),-0.5705399620494659,-1.3677698207601359,0.11888111888111888,0.48308759282586317,1.0,4/15,11.28%,SLC24A3;SLC9A9;SLC24A2;SLC9A1
prerank,N-acyltransferase activity (GO:0016410),0.5510461530287286,1.3654538442482997,0.12376237623762376,0.8217184665539192,1.0,6/32,10.44%,TGM2;NMT2;CERS4;GLYAT;PLAAT3;SMARCE1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.48631010565942,-1.3648451939223367,0.11597938144329897,0.481380057200781,1.0,11/27,18.75%,SLC41A1;SLC12A2;CNNM2;TUSC3;MAGT1;SLC9B2;CNNM4;MRS2;SLC8A2;SLC4A8;ATP2A3
prerank,AMP binding (GO:0016208),-0.6037112285122676,-1.3581906050513086,0.129979035639413,0.4896613910481848,1.0,7/11,18.16%,MPPED2;PFKP;PRKAG2;PRKAG3;ACSS2;PRKAG1;PFKM
prerank,tropomyosin binding (GO:0005523),-0.5451628885655967,-1.3565990220620718,0.10068649885583524,0.48571715433865603,1.0,3/16,5.39%,CALD1;S100A6;TMOD2
prerank,peptidoglycan binding (GO:0042834),0.668945789804444,1.355163598423136,0.1560798548094374,0.8535784761219767,1.0,2/10,6.35%,NOD1;PGLYRP2
prerank,anion:anion antiporter activity (GO:0015301),-0.5179816736949564,-1.3481037977670538,0.10632911392405063,0.49992975069002515,1.0,7/17,19.25%,SLC26A7;SLC26A2;SLC4A3;SLC4A2;SLC19A1;SLC26A6;SLC25A4
prerank,clathrin adaptor activity (GO:0035615),0.6202072818659703,1.3445534271596193,0.16283185840707964,0.8855992131534524,1.0,4/15,7.58%,HIP1;HIP1R;AP2B1;AP2A1
prerank,BMP binding (GO:0036122),0.6754323277972525,1.3441602193707498,0.14673913043478262,0.8727896888535116,1.0,4/11,6.59%,BMPR2;ENG;GREM1;SOST
prerank,Toll-like receptor binding (GO:0035325),0.654359657148391,1.3435522495924292,0.16236162361623616,0.8617115799817949,1.0,2/11,4.28%,DAB2IP;TIRAP
prerank,protein tyrosine kinase binding (GO:1990782),0.47757968331188605,1.3432301121929207,0.0886426592797784,0.849396155207152,1.0,16/71,10.90%,PTPN14;BMPR2;NEDD9;TJP2;PITPNM2;DOCK4;NCK1;GRB14;CEACAM1;DUSP22;ACVR1;CRK;PTPN1;GAS6;EPHA4;CBL
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.4108590998181082,-1.3424251740128117,0.0802675585284281,0.5050941293036121,1.0,16/53,15.94%,SLC7A11;SLC7A2;SLC1A3;SLC47A1;SLC1A5;SLC6A9;SLC1A2;SLC25A12;SLC66A1;SLC7A6;SLC43A1;SLC6A7;SLC25A13;SLC1A1;SLC22A2;SLC25A18
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.6280825300648951,1.3407511212817265,0.13953488372093023,0.8460808221811292,1.0,6/15,14.80%,SOCS2;PIK3R6;CISH;SLA2;SOCS6;SOCS4
prerank,transcription coregulator binding (GO:0001221),0.49694618219900044,1.338115876286577,0.12338593974175036,0.8442208259250226,1.0,11/50,9.12%,ESR1;PPARD;ZBTB16;LMO2;AHR;VGLL4;MTF2;TEAD2;CTBP1;NEK6;RPL23
prerank,protein serine/threonine kinase activity (GO:0004674),0.4025837868827468,1.3330093421542757,0.03470715835140998,0.8517885619621057,1.0,87/334,15.78%,PRKCH;RPS6KA5;BMPR2;SNRK;ERN1;ACVRL1;PRKD1;CDK6;DAPK1;NEK7;PIM3;PRKD2;BCR;PTK2B;STK10;PRKD3;MAP4K3;SIK1;CCNK;TAOK2;STK24;STK3;PKN3;PKN2;PAK2;PKN1;RPS6KA3;KALRN;STK4;LMTK2;MARK3;MAP3K9;IKBKB;RPS6KA1;HIPK1;ACVR2A;CDC42BPB;MAPK8;SRPK3;PLK2;MAST2;ULK1;LIMK2;AURKA;SIK3;ACVR1;TSSK6;DYRK1A;TNIK;SGK3;AKT2;NEK6;MAP3K11;AURKC;SLK;BRD4;CDK2;MAPKAPK3;MAPK11;NUAK1;AKT3;MAP3K13;SIK2;STK38;IRAK4;PIM1;RIPK1;MKNK2;RIPK2;TRIO;EIF2AK4;TGFBR2;TOP1;UHMK1;MAPK6;RIOK1;ACVR2B;MAP3K20;MYLK;NRBP1;PRKCG;PAK4;IRAK3;RPS6KA4;MAP4K2;CSNK1G2;CDKL4
prerank,ephrin receptor binding (GO:0046875),0.5746208361742586,1.3324654222453802,0.16129032258064516,0.8414685758670949,1.0,9/21,11.23%,ANKS1A;LYN;EFNA1;FYN;PIK3CG;CRK;PTPN1;CBL;ANKS1B
prerank,sequence-specific DNA binding (GO:0043565),0.394781119578363,1.3290992787227345,0.0051387461459403904,0.8441337737541733,1.0,90/590,11.89%,ERG;LEF1;ELK3;FLI1;FOXO1;LHX6;EPAS1;PBX1;TBX1;ESR1;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;SOX13;ELF2;HHEX;NR3C1;HIF1A;TGIF1;PKNOX2;PITX1;SOX18;TCF12;HMBOX1;MAFF;SOX9;KLF2;FOXF1;FOXQ1;ELK4;MBNL2;FOXL2;XBP1;TET3;TCF7L1;FOXF2;HOXA10;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;ELF5;FOSL1;ETS2;JUNB;KLF13;SPDEF;FOXN2;HOXD8;HOXD1;GMEB2;HNRNPD;NEUROD1;BACH2;NRL;CREM;CREB1;FOXK1;MYBBP1A;SOX4;MAFB;NFIB;SMG7;CREB3L4;SP2;KLF12;SMAD5;USF2;EGR3;TFAP4;POU2F1;CSRNP1;ACD;ATF6;CBFB;SP3;CEBPD;LONP1;PRDM2
prerank,protease binding (GO:0002020),-0.3640003707932303,-1.3287637030362385,0.029166666666666667,0.5328639410291899,1.0,24/99,8.13%,COL1A2;COL3A1;COL1A1;TIMP3;PRKN;BCL2;TIMP2;CCBE1;SLC2A13;F3;DPP4;FAP;ATP9A;ADAMTSL4;NTRK2;SELENOS;ITGAV;PSAP;LDLR;STIM1;ANXA2;AMFR;ECM1;BDKRB2
prerank,semaphorin receptor binding (GO:0030215),0.5684125903767402,1.3284644439494693,0.1583198707592892,0.8346863971736029,1.0,6/23,10.42%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;SEMA4D
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.637381332433013,1.3236189399846463,0.1724137931034483,0.8425078350078711,1.0,6/12,19.59%,NOD1;CASP1;RACK1;APAF1;CASP8AP2;CTSH
prerank,"DNA binding, bending (GO:0008301)",0.6308851505985311,1.3235780780240913,0.1551094890510949,0.8309581331587473,1.0,2/14,2.25%,LEF1;HHEX
prerank,calcium:sodium antiporter activity (GO:0005432),-0.6103909179775765,-1.3228837639190258,0.16363636363636364,0.5401196130104324,1.0,3/10,3.39%,SLC24A3;SLC8A3;SLC8A1
prerank,GTPase binding (GO:0051020),0.4179414232814469,1.3194960915210454,0.058419243986254296,0.8356220278550307,1.0,50/194,15.31%,FGD5;FNBP1L;UNC13B;CAV1;LCP1;SPTBN1;TBC1D30;EPS8;RASIP1;RIN3;SH3BP4;IQGAP1;FGD6;ARHGEF2;SRGAP2;GNB1;DOCK4;SGSM1;PAK2;EXPH5;PKN1;BICDL1;NCKAP1;ULK1;MYCBP2;IARS1;RUSC2;RASA1;GCC2;EXOC5;YBX3;EXOC4;OCRL;CYRIB;MYO1C;BNIP3;ANKFY1;CYFIP1;PICALM;RILP;CCDC186;EXOC8;EVI5;RABGAP1L;ERC1;TNPO3;STRN3;AIMP1;RAPGEF6;YBX1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5962386844043694,-1.3170130755638774,0.1540041067761807,0.5473042696548046,1.0,6/10,22.93%,GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5626226973814993,-1.3155695834261496,0.15053763440860216,0.5431897447822054,1.0,7/13,22.93%,GLRB;GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,glucose transmembrane transporter activity (GO:0005355),0.5964079467452869,1.3140757775871723,0.1956521739130435,0.8458796288335143,1.0,3/17,6.85%,SLC2A1;MFSD4A;PPBP
prerank,phosphatase activator activity (GO:0019211),0.602823509700147,1.31284918655959,0.17625899280575538,0.8389199639762588,1.0,9/14,27.10%,PPP2R5A;PPP2R5E;PPP2R5B;CALM1;FRS2;PHACTR4;B3GAT3;CALM3;PPP2R5C
prerank,general transcription initiation factor binding (GO:0140296),0.5496476606960896,1.3092618500941122,0.15220949263502456,0.8416739040122921,1.0,7/25,12.88%,ESR1;AHR;HHEX;TAF1B;YEATS2;RELA;GTF2A2
prerank,GTP binding (GO:0005525),0.4195586349184696,1.30681211188201,0.08373205741626795,0.8407562243283839,1.0,37/172,13.82%,RAB27A;TGM2;GCH1;INSR;GBP5;MFHAS1;GBP4;RAP1B;RHOJ;RALB;GBP7;KRAS;NRAS;RAC1;ARL4A;GNAT1;RAP1A;RHOBTB1;RAB2A;DYNC1LI1;RAB38;TUBE1;ARL5A;NUDT16;ARL8B;NMUR2;DRG2;RNF112;RAB26;RAB11B;RHOB;RAB31;RAB5A;RAB7A;EIF2B2;ATL1;GBP3
prerank,transcription cis-regulatory region binding (GO:0000976),0.39426077488615446,1.306625521889283,0.028199566160520606,0.8307288471055104,1.0,57/406,11.89%,LEF1;ELK3;FLI1;LHX6;EPAS1;DACH1;PBX1;SMARCA2;MEF2C;SOX7;NR5A2;AHR;ETV6;IRF2;FOXP1;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;RREB1;SOX17;ACTN4;ZFP57;SOX18;TCF12;FOSL2;SOX9;ZBTB46;FOXF1;XBP1;FOXF2;TCF7L2;ATMIN;KLF10;NR1I3;FOXA3;ASCL4;FOXN2;HOXD8;TCF3;NFKB1;CREM;FOXK1;TCF15;SOX4;FOXN3;ZBTB10;TFAP4;GABPB1;RB1;ATF6;SP3;SNAPC3;LONP1;PRDM2
prerank,double-stranded DNA binding (GO:0003690),0.38825990376031133,1.3053109043897053,0.015511892450879007,0.8252440409262507,1.0,69/531,10.34%,ERG;LEF1;ELK3;FLI1;LHX6;PBX1;TBX1;ESR1;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;ELF2;AIM2;NR3C1;TGIF1;PKNOX2;PITX1;SOX18;TCF12;HMBOX1;MAFF;SOX9;KLF2;FOXQ1;ELK4;MBNL2;FOXL2;XBP1;TCF7L1;HOXA10;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;ELF5;FOSL1;ETS2;JUNB;KLF13;SPDEF;FOXN2;HOXD8;HOXD1;GMEB2;NEUROD1;BACH2;NRL;CREM;CREB1;FOXK1;SOX4;CGAS;NFIB;CREB3L4;SP2;KLF12;SMAD5;USF2;EGR3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.5420780179657275,1.3044806405971878,0.1640378548895899,0.8182445399596117,1.0,5/27,6.07%,RNF125;DCUN1D3;RNF144B;FOXL2;RNF144A
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5245573344783724,1.3044057596062346,0.1752411575562701,0.808584343470048,1.0,10/30,16.68%,RPS6KA3;RPS6KA1;SERPINB9;XIAP;GAS6;CARD16;TNFAIP8;BIRC3;CAST;BIRC2
prerank,mRNA 3'-UTR binding (GO:0003730),-0.3845364626212896,-1.3043378907896443,0.07377049180327869,0.5649802011570222,1.0,19/79,16.23%,CELF2;RBMS3;CPEB1;DDX5;CPEB2;CPEB3;HNRNPA2B1;FXR2;DAZAP1;RBMS1;CPEB4;CIRBP;RBM4;CELF1;IGF2BP2;CSDC2;HNRNPU;ELAVL4;PCBP4
prerank,carbohydrate kinase activity (GO:0019200),-0.5854335008161107,-1.3031150561494826,0.15217391304347827,0.5595228838467878,1.0,4/11,16.09%,GALK2;NAGK;HK2;GALK1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.38442029564173824,1.3007424510684424,0.013333333333333334,0.8130334318640983,1.0,78/597,10.34%,ERG;LEF1;ELK3;FLI1;LHX6;PBX1;TBX1;ESR1;SMARCA2;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;SOX13;ELF2;HHEX;TAL1;STAT3;NR3C1;SOX17;TGIF1;PKNOX2;PITX1;SOX18;TCF12;HMBOX1;MAFF;SOX9;KLF2;FOXQ1;ELK4;MBNL2;FOXL2;XBP1;TCF7L1;HOXA10;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;ATMIN;KLF10;NR1I3;FOXA3;ELF5;FOSL1;ETS2;JUNB;KLF13;MCM10;SPDEF;FOXN2;HOXD8;HOXD1;GMEB2;NFKB1;NEUROD1;POLA1;BACH2;NRL;CREM;CREB1;FOXK1;SOX4;NFIB;CREB3L4;SP2;KLF12;SMAD5;USF2;EGR3
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6453155647784888,1.299823112601133,0.21818181818181817,0.8065537482581296,1.0,1/10,0.09%,SHANK3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.49489768273712753,1.2960747157362675,0.13213213213213212,0.8108974232310978,1.0,11/42,11.11%,SHE;YES1;FBXW7;PLCG2;BCAR3;LCK;RASA1;NEDD4;SAMSN1;CRK;ABL2
prerank,protein tyrosine kinase activity (GO:0004713),0.4338890344290263,1.2959744492282963,0.09595959595959595,0.8016964372404194,1.0,22/108,7.46%,TEK;FLT1;KDR;TIE1;EPHB4;INSR;PEAK1;LYN;PTK2B;YES1;FYN;SRMS;FLT4;LMTK2;JAK3;HIPK1;RET;DYRK1A;BMX;LCK;JAK1;PTK2
prerank,LRR domain binding (GO:0030275),-0.5251346287918129,-1.295182630856272,0.1689497716894977,0.5728395724974423,1.0,5/14,12.75%,ROBO1;PAWR;LRRFIP2;PMF1;ZXDC
prerank,ribonuclease activity (GO:0004540),0.46178848929958094,1.2863040089088225,0.1495601173020528,0.8281892226424611,1.0,14/56,14.46%,ERN1;SAMHD1;CNOT6;N4BP1;RNASE1;RNASEH2A;ANG;RNASE4;KHNYN;DICER1;INTS11;EXOSC1;CNOT7;ZC3H12C
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.6115621549652828,1.2859026124651471,0.2007168458781362,0.8201316146909624,1.0,3/13,7.41%,PIP5K1B;PIK3C2A;PIK3CG
prerank,nuclear receptor binding (GO:0016922),0.43066848615916226,1.281816458550905,0.11528822055137844,0.8263026419692234,1.0,22/111,12.24%,LEF1;TACC1;ESR1;FOXP1;HIF1A;KDM3A;ACTN4;DDX54;PKN1;NCOA1;TRIM68;TCF7L2;JMJD1C;ARID1A;KDM4C;NRIP1;CNOT1;SMARCE1;MMS19;DCAF1;OASL;ASXL1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3768217176847124,1.2810058259647594,0.016177957532861477,0.8198092777261983,1.0,100/732,10.72%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;AHR;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;SOX17;TGIF1;PKNOX2;PITX1;SOX18;TCF12;FOSL2;MAFF;SOX9;KDM6A;KLF2;FOXF1;FOXQ1;ELK4;SP6;FOXL2;XBP1;ZFP92;TCF7L1;FOXF2;HOXA10;H3-3A;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;JUNB;KLF13;LYL1;FOXN2;HOXD1;GMEB2;TCF3;NFKB1;NEUROD1;BACH2;NRL;ZNF2;CREM;CREB1;FOXK1;CHD2;SOX4;RELB;MAFB;BACH1;NFIB;CREB3L4;NRIP1;SP2;SKIL;KLF12;SMAD5;USF2;EGR3;FOXN3;TFAP4;POU2F1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.37704814116943386,1.2807200451889698,0.015197568389057751,0.8117932159385588,1.0,98/731,10.34%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;AHR;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;SOX17;TGIF1;PKNOX2;PITX1;SOX18;TCF12;FOSL2;MAFF;SOX9;KDM6A;KLF2;FOXF1;FOXQ1;ELK4;SP6;FOXL2;XBP1;ZFP92;TCF7L1;FOXF2;HOXA10;H3-3A;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;JUNB;KLF13;LYL1;HOXD1;GMEB2;TCF3;NFKB1;NEUROD1;BACH2;NRL;ZNF2;CREM;CREB1;TRIM24;FOXK1;CHD2;TCF15;SOX4;RELB;MAFB;BACH1;NFIB;CREB3L4;NRIP1;SP2;SKIL;KLF12;SMAD5;USF2;EGR3
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5043625110926756,-1.2776349882863178,0.16580310880829016,0.6143639917452379,1.0,7/16,18.10%,SLC26A7;SLC26A2;SLC26A6;SLC1A1;CLCN7;CFTR;SLC4A8
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.6281375093607147,1.2772627048803251,0.20275590551181102,0.8149808986554125,1.0,7/11,15.69%,DAB2IP;SASH1;TCF3;MAP3K11;STK38;TRAF6;MAP4K2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.6151570398861392,1.2771442740371952,0.22120658135283364,0.8065327994319806,1.0,4/11,14.63%,SGMS1;DPAGT1;GNPTAB;PIGF
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5252208497319205,-1.274894184273433,0.18615751789976134,0.6131335012271864,1.0,3/14,2.94%,ENPP1;FHIT;NUDT4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.5168591294836916,1.2725448458407804,0.1841704718417047,0.8139178237900462,1.0,10/33,16.32%,RNF125;DCUN1D3;RNF144B;FOXL2;RNF144A;SIAH1;TRAF6;ARIH2;RNF5;UBE3D
prerank,ligand-gated cation channel activity (GO:0099094),-0.3634998258519259,-1.272041414051381,0.08041958041958042,0.6122902733818851,1.0,22/75,18.63%,GRIN3A;GRIA2;P2RX4;GRIA3;GRIA1;KCNJ2;KCNJ13;GRIK4;GRIA4;GRIN2A;GRIK2;GRIK5;GRIK1;KCNJ10;GRIN2D;KCNN2;CCDC51;KCNJ8;KCNJ15;KCNJ6;CHRNA7;KCNN3
prerank,transcription coactivator binding (GO:0001223),0.5485403290870532,1.2703628665808486,0.2003257328990228,0.8135882239956805,1.0,6/20,9.12%,ESR1;PPARD;AHR;VGLL4;TEAD2;RPL23
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.5658311522626376,-1.270156865081318,0.2185430463576159,0.6086119065762318,1.0,1/10,0.52%,DPYSL3
prerank,GDP binding (GO:0019003),0.4640892319669966,1.2695546980613188,0.15198863636363635,0.8078584348503004,1.0,20/63,16.87%,RAB27A;RAP1B;RALB;KRAS;NRAS;GNAT1;RAP1A;RAB2A;DYNC1LI1;ARL8B;RAB12;RAB11B;RAB31;RAB5A;RAB7A;RAB5B;RAB18;GNAI3;RHEB;RAB8B
prerank,frizzled binding (GO:0005109),-0.43519321178549863,-1.2691650984883869,0.14202898550724638,0.6026453106146012,1.0,13/34,17.67%,WNT4;RNF43;WNT6;WNT9A;RYK;LRP6;SFRP1;FZD1;WNT16;FZD7;WNT11;DVL1;MYOC
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3823106529107635,1.2682121170086744,0.040992448759439054,0.8043697084366864,1.0,97/431,15.69%,RPS6KA5;RAB27A;TGM2;SNRK;ERN1;ACVRL1;GCH1;CDK6;INSR;DAPK1;MYH9;PEAK1;GBP5;PRAG1;MFHAS1;GBP4;MAP4K3;SIK1;RAP1B;STK3;RHOJ;STK4;LMTK2;RALB;GBP7;SYN3;CDC42BPB;MAST2;ATP1A3;ATP1A1;TAP2;MTHFD1L;SIK3;ACVR1;TSSK6;KRAS;NRAS;RAC1;ARL4A;STK26;GNAT1;MTREX;MLKL;RAP1A;RHOBTB1;TRIP13;RAB2A;DYNC1LI1;RAB38;SMARCA5;HASPIN;AKT2;NEK6;PXK;ABCD4;TUBE1;ARL5A;NUDT16;ARL8B;NMUR2;TWF2;ATP7B;PSMA6;DRG2;AKT3;SIK2;STK38;RNF112;LONP1;PIM1;ABCD1;RAB26;MKNK2;RAB11B;RHOB;HSP90AB1;TOP1;UHMK1;PFKL;TRIB1;RAB31;RAB5A;MTPAP;RAB7A;ABCG1;EIF2B2;ATL1;GBP3;MAP3K20;RAB32;PMVK;PNPLA8;RAB6A;PANK3;IRAK3;RPS6KA4;MAP4K2
prerank,protein phosphatase 1 binding (GO:0008157),0.5452977739047655,1.267248700195453,0.21440536013400335,0.799488162729307,1.0,4/21,8.49%,PPP1R16B;KCNQ1;PPP1R9B;SHOC2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.46960173456066706,1.2663494536062678,0.17024320457796852,0.7948988718838113,1.0,14/54,15.26%,HDAC9;ACER2;TGM2;GLS2;GLS;ASAH2;SIRT5;PM20D2;HINT1;MIER1;SIRT6;ACR;ASAH1;FAAH
prerank,guanyl ribonucleotide binding (GO:0032561),0.4025864029011204,1.26329789792965,0.09016393442622951,0.7976583869623787,1.0,52/196,17.63%,RAB27A;TGM2;GCH1;INSR;PDE2A;GBP5;MFHAS1;GBP4;CNGB1;RAP1B;RHOJ;RALB;GBP7;RAPGEF2;KRAS;NRAS;RAC1;ARL4A;GNAT1;RAP1A;RHOBTB1;RAB2A;DYNC1LI1;RAB38;TUBE1;ARL5A;NUDT16;ARL8B;RAB12;NMUR2;DRG2;RNF112;RAB26;RAB11B;RHOB;RAB31;RAB5A;RAB7A;EIF2B2;ATL1;GBP3;RAB5B;RAB18;RAB32;GNAI3;RAB6A;RHEB;RHOA;RAB8B;RHOT1;ADSS2;RND1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.584189487971727,-1.260944427255006,0.20043103448275862,0.6170191212782538,1.0,3/10,9.73%,DSE;RENBP;DSEL
prerank,inward rectifier potassium channel activity (GO:0005242),-0.46386363941867004,-1.2602182771522812,0.18181818181818182,0.6104223177980789,1.0,9/24,18.63%,ABCC9;KCNJ2;KCNJ13;KCNJ10;KCNN2;KCNJ8;KCNJ15;KCNJ6;KCNN3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5546038975899732,-1.2554392442413016,0.18683651804670912,0.6153825785102709,1.0,2/11,5.79%,SLC22A4;SLC25A47
prerank,lysine N-methyltransferase activity (GO:0016278),-0.4793352288338873,-1.2544832089494184,0.1891891891891892,0.6095630582295279,1.0,10/20,28.16%,KMT5A;EHMT2;SETD4;VCPKMT;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;SETD7;EEF1AKMT3
prerank,acid-thiol ligase activity (GO:0016878),-0.5306725032211042,-1.2518957302234863,0.1867612293144208,0.6084853616553864,1.0,4/13,14.95%,ACSL1;AASDH;AACS;ACSS2
prerank,E-box binding (GO:0070888),0.4979656271399925,1.2513060035713488,0.19349845201238391,0.8323259518474462,1.0,8/34,12.41%,AHR;TAL1;TCF4;TCF3;NEUROD1;TCF15;TFAP4;MAX
prerank,retinoid X receptor binding (GO:0046965),0.617462109413275,1.2381981517350673,0.25925925925925924,0.8709010752800086,1.0,2/11,9.90%,TACC1;NRIP1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.4368860322383517,-1.2358668938218138,0.1820580474934037,0.6447448171006946,1.0,11/27,19.96%,SLC8A3;SLC41A1;SLC9A9;SLC8A1;SLC9A1;SLC9B2;CNNM4;SLC8A2;SLC4A8;SLC8B1;SLC9A8
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.36340439003432534,1.2345494955583531,0.022357723577235773,0.8751721270912673,1.0,107/831,10.72%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;LHX6;EPAS1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;ETV6;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;TAL1;STAT3;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;SOX17;TGIF1;PKNOX2;PITX1;ACTN4;ZFP57;SOX18;TCF12;FOSL2;MAFF;SOX9;KDM6A;ZBTB46;KLF2;FOXF1;FOXQ1;ELK4;SP6;FOXL2;XBP1;ZFP92;TCF7L1;FOXF2;HOXA10;H3-3A;TCF7L2;TCF4;TEAD2;PITX3;ESRRG;KLF10;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;JUNB;ASCL4;KLF13;LYL1;HOXD8;HOXD1;GMEB2;TCF3;NFKB1;NEUROD1;BACH2;NRL;ZNF2;CREM;CREB1;FOXK1;CHD2;TCF15;SOX4;RELB;MAFB;BACH1;NFIB;CREB3L4;NRIP1;SP2;SKIL;KLF12;SMAD5;USF2;EGR3;ZBTB10;TFAP4;POU2F1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.38313135323848707,1.2301323754148328,0.11672278338945005,0.8822445011616341,1.0,59/248,17.63%,DNM3;RAB27A;GNAQ;GCH1;MYH9;RAB11A;GBP5;GBP4;RASD2;GNB1;RAP1B;KIF26A;GPN3;RHOJ;RALB;SMCHD1;GBP7;GNAI2;ABCA3;KRAS;NRAS;RAC1;GNAT1;RAP1A;RHOBTB1;RAB2A;GNA12;RAB38;MYO1E;ARL8B;DRG2;RNF112;MYL6B;ABCD1;RAB43;RAB11B;RHOB;HBS1L;GNA13;RAB31;RAB5A;TOR3A;RAB7A;ATL1;GBP3;RAB5B;NKIRAS1;RAB18;RAB32;GNAI3;RAB6A;IRGM;RHEB;MFN1;RHOA;RAB8B;RHOT1;EEF2;RND1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.602287752740271,1.2298881411392237,0.23581560283687944,0.8747071859277591,1.0,2/10,1.65%,SLCO2B1;SLCO2A1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.6019058981215115,1.2272916659377775,0.27425373134328357,0.8755458997526551,1.0,3/10,10.68%,ANKRD13A;USP15;FAN1
prerank,cytokine activity (GO:0005125),-0.31923931852180853,-1.2267447144723247,0.08376963350785341,0.6624755713833984,1.0,23/131,14.75%,BMP6;IL34;WNT4;BMP5;BMP7;IL18;WNT6;BMP4;FGF2;CXCL16;WNT9A;IL16;TNFRSF11B;VEGFA;CXCL12;INHBA;TGFB3;TGFB2;WNT16;GDF11;GDF1;IL17D;WNT11
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.40876379163560334,-1.2262112845497333,0.1588235294117647,0.6559835289295911,1.0,8/38,10.33%,SERPING1;TFPI;SERPINH1;SERPINE2;SERPIND1;ANXA2;SERPINF1;SERPINE1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.47291700184410146,1.2256748812675171,0.20592592592592593,0.8732287234995758,1.0,1/44,0.03%,MECOM
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4347975922477068,1.2238792275911445,0.18688981868898186,0.8714655739928604,1.0,10/71,6.08%,PTPRB;PTPRG;PTPN14;PTPRM;PTPN12;PTPRJ;PTP4A2;PTPRK;MTMR6;DUSP22
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5639989572068373,1.2206370276226581,0.24125874125874125,0.8752917238289125,1.0,7/14,17.97%,MINDY1;MINDY2;USP15;ATXN3;YOD1;DESI2;USP7
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4407690852145367,1.2204597571549185,0.17397260273972603,0.8678813681701195,1.0,10/60,5.59%,NRP2;TEK;FLT1;KDR;TIE1;EPHB4;INSR;FLT4;LMTK2;RET
prerank,metalloaminopeptidase activity (GO:0070006),-0.4836504895653885,-1.2149455400911564,0.2403846153846154,0.6797894343965288,1.0,4/16,7.33%,MMP14;MMP16;NPEPPS;ENPEP
prerank,potassium channel regulator activity (GO:0015459),-0.3765715675065649,-1.2138393377626504,0.14619883040935672,0.6744419696640692,1.0,11/49,9.95%,KCNIP3;KCNIP4;WNK4;ABCC9;DLG1;SLC5A3;KCNMB2;KCNS3;KCNAB1;DPP6;WNK1
prerank,DNA-binding transcription factor binding (GO:0140297),0.383310438443827,1.2137413807357829,0.1396713615023474,0.884812795022621,1.0,36/189,14.16%,HDAC9;LDB2;PPARD;MEF2C;LMO2;CRTC1;NFATC1;HHEX;TAL1;STAT3;HDAC7;TLE4;SIK1;PITX1;TCF12;GTF2I;EIF4E;TCF7L2;FBP1;TCF3;NEUROD1;CTBP1;CREM;CREB1;NEK6;ZFPM1;MAD2L2;USF2;SPEN;RB1;MIER1;RELA;PTMA;MEF2A;NPM1;MEF2D
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.48699002220052146,1.213573850061519,0.23374613003095976,0.8774591349766321,1.0,12/35,17.69%,FOXP1;NR3C1;H3-3A;KLF10;TAF1B;RRN3;POU2F1;SNAPC3;RELA;NPM1;PIH1D1;STAT1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4240693743453804,1.2064216032450792,0.21646746347941567,0.895493058492035,1.0,19/85,15.84%,PLA2G4A;ABHD2;PGAP1;LIPE;BCHE;ENPP2;PLA2G2D;CA1;PON2;LPL;PLAAT3;PTRH1;GDPD1;PNPLA2;PNPLA6;FAAH;NDST3;CA2;ESD
prerank,manganese ion binding (GO:0030145),-0.3799216075324108,-1.2042012112294924,0.17746478873239438,0.694027475864078,1.0,8/48,8.76%,MPPED2;ADCY2;LARGE1;ME1;FAM20C;NEK4;PPM1M;TDP2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.5596505836877603,1.2005040939028044,0.25254237288135595,0.9092950546945529,1.0,2/16,3.22%,CD38;BST1
prerank,SUMO transferase activity (GO:0019789),-0.47405430343376986,-1.2002949984506093,0.23897911832946636,0.696297779957052,1.0,6/16,19.12%,HDAC4;MDM2;PIAS1;PIAS3;TRIM28;CBX4
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5369320866255236,1.1994184005641488,0.2542955326460481,0.9051536250466918,1.0,6/18,14.80%,SOCS2;PIK3R6;CISH;SLA2;SOCS6;SOCS4
prerank,kinase binding (GO:0019900),0.3582494194839283,1.1979740874419211,0.10180275715800637,0.9023197065607284,1.0,94/434,14.29%,FRMD5;CAV1;ESR1;UTRN;SLC12A7;PDE8A;ACVRL1;SMAD1;PLCG1;PPP2R5A;IQGAP1;DAB2IP;ADAM10;FAS;STAT3;NR3C1;HDAC7;TRIM14;HIF1A;MSN;PTPRJ;SIK1;CCNK;TTC28;PLCG2;CAV2;PPP1R12A;PAK2;RPS19;PIK3IP1;IKBKB;CEACAM1;GHR;PTPRK;TRIM68;TCF7L2;ATP1A4;LRBA;AURKA;RPS7;SKAP1;IFNAR2;RAC1;SASH1;CDKN1B;TRIB3;BCAR3;GNAT1;HNRNPA0;LCK;PTK2;AP2A1;GRB7;STX1A;TRPV4;RHOBTB1;CASP1;POLA1;WWC2;RPTOR;NEK6;ARHGEF7;LLGL1;CRK;RELB;PTPN1;RICTOR;MAP2K3;BCL2L1;RAD23A;PRKAB1;BTG1;RB1;MAP3K13;IRAK4;PEBP1;CARD16;RHOB;RELA;ADIPOR1;CEP68;ZFP36;MYH6;WARS1;HSP90AB1;PFKL;CDC25C;LRRC14;GSKIP;RPS6;NPM1;TRAF6;BCL2L14;APC
prerank,GABA-A receptor activity (GO:0004890),-0.47445174021993675,-1.1932778044457972,0.2459016393442623,0.7078041237800502,1.0,8/18,22.93%,GABRG2;GABRA2;GABRB1;GABRB3;GABRG3;GABRA1;GABRA5;GABRA3
prerank,alpha-actinin binding (GO:0051393),-0.44455238377757306,-1.1911000975975778,0.23136246786632392,0.7055658367416762,1.0,5/24,4.17%,CACNA1C;CACNA1D;DAG1;PALLD;PDLIM7
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.44434311640805624,1.1888075962251778,0.2363367799113737,0.9277144317755089,1.0,12/49,10.38%,MINDY1;BABAM2;RNF169;MINDY2;UBL7;BRCC3;ZRANB1;IKBKG;ZFAND2B;RAD18;RAD23A;TNIP1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.47416815160888137,1.1883044113486347,0.250384024577573,0.9214242192747821,1.0,15/34,22.17%,CNOT6;PAN3;CNOT6L;ISG20;ANGEL2;CNOT1;REXO2;CNOT2;CNOT7;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,G protein-coupled receptor activity (GO:0004930),0.36857669816134014,1.1827421319685494,0.17411225658648338,0.9345647713879762,1.0,15/239,6.51%,ADGRG6;ADGRL4;CALCRL;CYSLTR1;ADGRL2;NPR1;S1PR1;ADGRG3;ADGRE5;ADGRG1;ADRB1;CX3CR1;HCRTR1;MCHR1;OPN4
prerank,hexosyltransferase activity (GO:0016758),0.39728296818645326,1.181229075576958,0.22710163111668757,0.9325057362567147,1.0,13/101,8.79%,CSGALNACT1;TMTC2;LFNG;MGAT4A;GBE1;MFNG;B3GNT3;B4GALT4;MTAP;B3GNT4;B4GALT5;B4GAT1;B3GNT6
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5315606303111149,-1.180082936874998,0.2947845804988662,0.7292030210171394,1.0,4/10,13.11%,B3GALT1;B4GALT6;B3GALT5;B4GALT7
prerank,ATP binding (GO:0005524),0.3648569822671301,1.1796528217639484,0.16402714932126697,0.930596935215666,1.0,59/266,15.69%,RPS6KA5;SNRK;ERN1;ACVRL1;CDK6;INSR;DAPK1;MYH9;PEAK1;PRAG1;MAP4K3;SIK1;STK3;STK4;LMTK2;SYN3;CDC42BPB;MAST2;ATP1A3;ATP1A1;TAP2;MTHFD1L;SIK3;ACVR1;TSSK6;STK26;MTREX;MLKL;TRIP13;SMARCA5;HASPIN;AKT2;NEK6;PXK;ABCD4;TWF2;ATP7B;AKT3;SIK2;STK38;LONP1;PIM1;ABCD1;MKNK2;HSP90AB1;TOP1;UHMK1;PFKL;TRIB1;MTPAP;ABCG1;EIF2B2;MAP3K20;PMVK;PNPLA8;PANK3;IRAK3;RPS6KA4;MAP4K2
prerank,ion channel inhibitor activity (GO:0008200),0.46613282153698576,1.1773961612245558,0.25960061443932414,0.9309367480950247,1.0,10/35,12.71%,NEDD4L;FKBP1A;STX7;RASA1;STX1A;NEDD4;MCUB;VAMP8;STX8;RACK1
prerank,chemorepellent activity (GO:0045499),0.4958344627340141,1.1765414391775941,0.2688679245283019,0.9262053973029358,1.0,3/25,1.68%,SEMA6A;SEMA5B;SEMA7A
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.374175680298825,1.1761919941314916,0.2,0.919903102043552,1.0,18/188,6.46%,FLI1;PBX1;SMARCA2;MEF2C;SOX7;NR5A2;AHR;SOX13;HHEX;TAL1;STAT3;SOX17;SOX18;TCF12;LIN54;TCF7L2;ATMIN;FOXA3
prerank,voltage-gated cation channel activity (GO:0022843),-0.3264268013191303,-1.1748010136088867,0.14418604651162792,0.7364951957873295,1.0,18/97,10.69%,CACNA1C;CACNA2D3;CACNA2D1;KCNB2;CACNA1D;GRIN3A;KCNMA1;KCNQ3;KCND2;KCND3;CACNB2;ITGAV;KCNC2;KCNS3;KCNQ4;CACNB1;KCNQ5;GRIN2A
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5212678826514895,-1.1723613441451435,0.27880184331797236,0.7353511358864919,1.0,2/11,2.65%,EGFR;MAP3K5
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3958557534463881,1.170401178612038,0.2266325224071703,0.93367006687078,1.0,22/100,15.30%,CERT1;PLA2G4A;ARAP3;PARD3;HIP1;HIP1R;IQGAP1;DAB2IP;DENND1B;TECPR1;PLEKHA5;SNX3;PLEKHA8;SNX24;ARAP2;ANKFY1;SNX11;KIF16B;CYTH3;SNX13;ATG2A;ATG2B
prerank,protein homodimerization activity (GO:0042803),0.3456506254651888,1.169810479540911,0.09948186528497409,0.9283786181268269,1.0,88/589,10.77%,ABCG2;PECAM1;ZHX3;NOD1;ST6GAL1;TBX1;CADM1;RBPMS;ZBTB16;ERN1;F11R;GCH1;B2M;AHR;RASIP1;LRRFIP1;PDGFB;HIP1;HIP1R;MYH9;IL6R;DAB2IP;FZD4;HHEX;PDE2A;ADAM10;STAT3;GBP5;TPST2;GBP4;SRGAP2;STK10;TRIM14;TPD52;KLHL7;TPD52L1;ACTN4;TBC1D22A;FLT4;CAV2;CAT;ABCB7;ACTN1;SPPL2A;STK4;SMCHD1;MAP3K9;IKBKB;CEACAM1;GHR;GREM1;TRIM68;MTHFD1L;BOK;CCDC88A;DROSHA;MID2;TOX3;ACVR1;EEA1;SH3GLB1;STK26;SYNE1;PDGFC;TCF3;PKD2;LPL;CITED1;GSTA4;ANG;MAP3K11;SLK;DEFA6;CHMP4A;CHMP4B;NUDT16;CEP57;IKBKG;CSF1;IZUMO1;BCL2L1;INPP5F;USF2;CYP2R1;TFAP4;GGCT;SCARB2;BNIP3
prerank,solute:sodium symporter activity (GO:0015370),-0.4047694918371995,-1.1665931330759287,0.25405405405405407,0.7437960065120067,1.0,6/27,18.10%,SLC4A10;SLC5A3;SLC20A1;SLC5A6;SLC5A11;SLC4A8
prerank,acylglycerol lipase activity (GO:0047372),0.5791529253938692,1.1654172715589417,0.3248175182481752,0.9360481808025308,1.0,2/11,3.88%,ABHD2;LIPE
prerank,DNA binding (GO:0003677),0.34333334741635696,1.1653305087129286,0.09644670050761421,0.9290375994834446,1.0,101/694,13.44%,MECOM;ERG;LEF1;FLI1;FOXO1;EPAS1;PBX1;TBX1;SMARCA2;APP;PPARD;TSHZ2;ZBTB16;NR5A2;AHR;ZIC3;LRRFIP1;IRF2;SOX13;HHEX;STAT3;AIM2;SAMHD1;HIF1A;ARID3B;TSHZ1;RPS15;HMBOX1;MAFF;SOX9;KLF2;ZNF292;FOXF1;ELK4;FOXL2;XBP1;TCF7L1;FOXF2;MTF2;TCF7L2;TCF4;LIN9;CNBP;ETS2;JUNB;LYL1;MCM10;SPDEF;RPA1;TCF3;ARID1A;NEUROD1;POLA1;NRL;CDT1;CREM;SMARCA5;EZH1;TAF4B;ANG;MYBBP1A;SUB1;APLP2;CHD2;RAD51D;CGAS;MAFB;BRIP1;RNF4;NFIB;MEIOB;RAD18;RAD23A;KLF12;USF2;GLYR1;TFAP4;FAN1;POU2F1;CSRNP1;RPS27;ZMYND11;ATF6;UNG;CBFB;SNAPC3;LONP1;MCM9;PRDM2;OASL;RELA;MAX;WDR76;RPL6;SLTM;ERCC4;TOP1;IMPDH1;ZBTB6;ACR;ESRRB
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.42094390624644973,1.1629503208526957,0.24162011173184358,0.9299919942172213,1.0,12/60,6.28%,TEK;FLT1;KDR;TIE1;EPHB4;ACVRL1;INSR;FLT4;LMTK2;ACVR2A;RET;ACVR1
prerank,phosphotyrosine residue binding (GO:0001784),0.4594489903305931,1.1608867479623568,0.2870514820592824,0.9296453388476906,1.0,9/37,11.11%,SHE;YES1;PLCG2;BCAR3;LCK;RASA1;SAMSN1;CRK;ABL2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5685984019723573,1.1606831417671146,0.3191881918819188,0.9232202933584713,1.0,1/11,3.14%,CNGB1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4532144432124019,1.1600342809349737,0.2764350453172205,0.9182206322052557,1.0,11/38,15.30%,PLA2G4A;PARD3;HIP1;DAB2IP;TECPR1;PLEKHA5;SNX3;KIF16B;SNX13;ATG2A;ATG2B
prerank,dynactin binding (GO:0034452),-0.4916727137160307,-1.1545547392758222,0.2837209302325581,0.7709446768510887,1.0,5/12,13.82%,BICD1;SNX6;SNX5;HTT;BICD2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5657424864759335,1.1510783691934272,0.3427495291902072,0.9414705367878347,1.0,2/10,10.68%,ANKRD13A;FAN1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5093494468324826,1.1506559192098116,0.2977624784853701,0.935826141746521,1.0,5/18,6.28%,BMPR2;ENG;ACVRL1;ACVR2A;ACVR1
prerank,cholesterol transfer activity (GO:0120020),0.5250325954873524,1.1501951039764113,0.32792207792207795,0.9302882355766604,1.0,2/16,3.09%,PLTP;STARD5
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5492225783792782,1.1501909571803401,0.3387387387387387,0.9234266508063848,1.0,5/12,21.48%,SPPL2A;PSEN1;SPPL3;DDI2;NAPSA
prerank,zinc ion binding (GO:0008270),0.35395376047008464,1.149256539300314,0.20883977900552486,0.9196905244849884,1.0,59/293,17.13%,MYRIP;SHANK3;TNFSF10;RNF125;GCH1;MSRB3;ARHGEF2;PDE2A;GDA;SAMHD1;KLF7;TES;TET3;ENPP2;ASAH2;MYCBP2;PAM;EEA1;ADAMDEC1;SIRT5;ERAP1;KDM4C;PRIMPOL;ZNF2;TRIM24;PGGT1B;PTPN1;AFM;SIAH1;RC3H1;RPS27;ZMYND11;PITRM1;RNF112;PRDM2;ADH1A;SIRT6;TET2;SORD;TMEM163;AOC1;IFIH1;ACR;RPS29;S100A9;MSRB2;KAT6A;ARIH2;ACE;RNF5;CA2;ZFPL1;TAB3;CHORDC1;BIRC2;KDM5C;APIP;KDM4A;ZNF8
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5486503244203799,1.1483618006832437,0.332703213610586,0.9160524542951756,1.0,5/12,18.35%,PIK3C2A;PIK3R6;PIK3CG;IPMK;PIK3C2B
prerank,store-operated calcium channel activity (GO:0015279),-0.5162354305056014,-1.1481150135314213,0.31446540880503143,0.7825673541114501,1.0,6/10,13.69%,TRPC3;TRPC6;TRPC1;TRPC4;TRPC5;ORAI2
prerank,potassium channel activity (GO:0005267),-0.31783767036487054,-1.1466179146533138,0.17803030303030304,0.7785879893358144,1.0,22/89,14.46%,KCNK2;KCNB2;KCNK5;KCNMA1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNMB2;KCNS3;KCNQ4;GRIK4;TMEM38A;KCNQ5;GRIK2;GRIK5;KCNA6;GRIK1;KCNT1;KCNN2;CCDC51
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.4390275069716204,-1.145748328307352,0.293398533007335,0.7726616544421162,1.0,5/21,18.45%,GRM5;GRIA1;GRM1;CHRNA7;CHRFAM7A
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.3519250273751769,-1.1455934296261876,0.22653721682847897,0.7650010373097313,1.0,12/55,9.52%,SLC24A3;CACNA1D;PKD1;MCU;CACNB2;TRPC3;ANXA2;ANXA6;TRPC1;ATP2A2;RYR2;SLC24A2
prerank,sterol transfer activity (GO:0120015),0.5188744799910506,1.1446624955697802,0.32247557003257327,0.9214668642653601,1.0,2/17,3.09%,PLTP;STARD5
prerank,hormone receptor binding (GO:0051427),0.52839433837392,1.1440869727405105,0.3185840707964602,0.9167461239727686,1.0,2/14,7.27%,SOCS2;JAK1
prerank,transcription corepressor binding (GO:0001222),0.47567699004051656,1.1434824302683626,0.3066884176182708,0.9121212106242813,1.0,6/27,11.14%,ESR1;ZBTB16;MTF2;CTBP1;NEK6;CNOT2
prerank,phosphate ion binding (GO:0042301),0.573504249758277,1.1420327679504907,0.3462246777163904,0.9105989905060006,1.0,4/10,19.80%,PDE2A;RELA;ADSS2;PNP
prerank,intracellular chloride channel activity (GO:0061778),0.5126634640074619,1.1400685950373832,0.3120567375886525,0.9041999730331359,1.0,4/16,10.58%,ANO2;TTYH2;NMUR2;ANO6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.5126634640074619,1.1400685950373832,0.3120567375886525,0.9041999730331359,1.0,4/16,10.58%,ANO2;TTYH2;NMUR2;ANO6
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5127510495976595,-1.1398003413971012,0.3133047210300429,0.7742177863519505,1.0,3/11,4.90%,KCNK2;KCND2;KCND3
prerank,serine-type peptidase activity (GO:0008236),-0.3171952923188909,-1.1372104464326418,0.19327731092436976,0.7741765547486119,1.0,12/96,9.22%,F3;RHBDL3;DPP4;HTRA3;PCSK5;FAP;HTRA1;NAALAD2;KLK2;PLAT;RHBDF1;MMP2
prerank,phospholipase activator activity (GO:0016004),-0.5076133309802728,-1.13503646009781,0.3219178082191781,0.7722603889991825,1.0,3/10,10.18%,ARHGAP6;SRC;STX4
prerank,protein phosphatase regulator activity (GO:0019888),0.42195800333084577,1.1340148461565547,0.3004172461752434,0.9177646652537902,1.0,21/53,21.63%,PPP1R16B;PPP2R5A;PPP1R2;PPP1R9B;LMTK2;PPP2R2C;PPP2R5E;PPP2R5B;SHOC2;PPP2R3A;PPP2R2D;MGAT5;RCAN1;PPP1R7;CALM1;PPP2R2A;EIF2AK2;PPP2R1A;PPP2R1B;PPP4R1;PHACTR4
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.492850737531473,1.1340054673351088,0.2931596091205212,0.9114695149036729,1.0,3/21,8.30%,POLK;PRIMPOL;POLA1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.36255906011881445,1.133876434207919,0.23905325443786982,0.9055736430054652,1.0,34/181,12.89%,LDB2;TACC1;PPARD;LMO2;NFATC1;TAL1;STAT3;HIF1A;NFKBIA;PITX1;ACTN4;GTF2I;NCOA1;DLL1;DTX3L;TCF7L2;FBP1;DNAJA1;TCF3;ARID1A;NEUROD1;CREB1;TAF4B;ZFPM1;NRIP1;MAD2L2;PSMA6;SMARCE1;SPEN;RB1;GABARAPL1;MIER1;RELA;RNF25
prerank,endopeptidase activity (GO:0004175),-0.2797270067588739,-1.1335613286578927,0.10317460317460317,0.768794866904042,1.0,40/257,12.49%,TRABD2B;ADAMTS12;ADAMTS2;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS10;ADAMTS5;F3;RHBDL3;DPP4;HTRA3;PCSK5;ADAMTSL1;FAP;MMP14;ADAMTS17;ADAMTSL4;MMP16;USP24;USP11;ADAM19;ADAMTS15;TASP1;ADAMTS1;ADAM33;KLK2;PLAT;USP13;RHBDF1;SFRP1;MMP2;USP49;USP33;ADAMTS14;USP10;ADAM9;MMP11;KDM8
prerank,myosin binding (GO:0017022),0.4182483819936156,1.1329016357032267,0.2789317507418398,0.9026035257574956,1.0,9/55,9.05%,MYRIP;SHROOM4;RAB11A;SHROOM1;NKD2;LMTK2;SPATA6;LLGL1;USH2A
prerank,solute:proton symporter activity (GO:0015295),0.5103301133467659,1.1322531656074022,0.32413793103448274,0.898619552358245,1.0,4/16,9.81%,SLC39A8;SLC2A9;SLC15A2;SLC15A1
prerank,vinculin binding (GO:0017166),0.551040496344062,1.1319417886130705,0.3648148148148148,0.8935821215485027,1.0,6/11,12.77%,UTRN;PXN;ACTN1;CTNNA1;SYNM;RTCB
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5412549799164037,1.1292959506326237,0.352622061482821,0.8959775435619858,1.0,4/12,17.69%,TRAF1;BABAM2;TRAF6;STAT1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4977616494037814,-1.1278928435164508,0.3484848484848485,0.778336056394623,1.0,5/11,13.03%,TRPC3;TRPC6;TRPC1;TRPC4;TRPC5
prerank,small GTPase binding (GO:0031267),0.36402739307238235,1.1275630585746235,0.2411764705882353,0.8957158368994845,1.0,35/169,13.06%,FGD5;UNC13B;CAV1;TBC1D30;EPS8;RIN3;SH3BP4;IQGAP1;FGD6;ARHGEF2;SRGAP2;DOCK4;SGSM1;PAK2;EXPH5;PKN1;BICDL1;NCKAP1;ULK1;MYCBP2;RUSC2;GCC2;EXOC5;YBX3;EXOC4;OCRL;CYRIB;MYO1C;ANKFY1;CYFIP1;PICALM;RILP;CCDC186;EXOC8;EVI5
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.48800970143907507,-1.127016001864554,0.32798165137614677,0.7732010948167269,1.0,3/12,7.17%,IRS1;GAB2;SHC1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4642309991238781,-1.126373060709798,0.3144208037825059,0.7674772422579179,1.0,8/15,10.63%,HS3ST3A1;HS3ST3B1;HS6ST3;HS2ST1;HS3ST4;HS6ST2;HS3ST5;HS6ST1
prerank,ubiquitin protein ligase binding (GO:0031625),0.34974758448939425,1.12617517331842,0.24303232998885171,0.8941371676584197,1.0,71/253,19.83%,FOXO1;FZD6;FZD4;MFHAS1;FBXW7;HIF1A;TNFRSF1B;NFKBIA;PRKAR2B;CASP8;TRAF1;NKD2;TMBIM6;RALB;SMAD7;HERC2;PRR5L;CD40;TRIB3;DNAJA1;ATXN3;SNCAIP;ARRB1;JAK1;UBE2G1;ARRDC1;WRAP53;NEK6;RPL23;IKBKG;SPOPL;RAD18;SMAD5;CXCR4;SUMO2;MC4R;MC1R;RB1;CUL1;RIPK1;GABARAPL1;RELA;PA2G4;HSP90AB1;ASB4;TRIB1;TXNIP;NDUFS2;UBE2K;TRAF6;APC;MID1;UBXN1;BAG4;CHEK2;RPL11;KDM4A;NEDD8;CUL3;YOD1;BAG1;USP7;RNF40;PRKACB;CUL2;USP25;BCL10;TSG101;SMAD2;NLK;GPI
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.536935434357834,1.1254338379568858,0.33891992551210426,0.8905140615357967,1.0,3/12,9.15%,CDK6;CCNK;BRD4
prerank,ubiquitin-specific protease binding (GO:1990381),-0.4336785583127357,-1.123995867871373,0.2995169082125604,0.7664738601224046,1.0,3/19,7.20%,PRKN;SELENOS;AMFR
prerank,Tat protein binding (GO:0030957),0.5707284554699282,1.1235968983592435,0.3734513274336283,0.8902348642624999,1.0,5/10,16.04%,DLL1;DNAJA1;GABARAPL1;NPM1;CTDP1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.48823478089695316,-1.1234035277788146,0.33995584988962474,0.7608283235513178,1.0,6/12,7.17%,IGF1;IRS1;GNAS;IGF2;YWHAG;SHC1
prerank,histone deacetylase binding (GO:0042826),0.38387426607941294,1.120369073472485,0.2625994694960212,0.8942412482149003,1.0,18/88,14.68%,LEF1;HDAC9;MEF2C;TAL1;PKN2;PKN1;MAPK8;HOXA10;PHF6;SP2;TFAP4;MIER1;RELA;HSP90AB1;MEF2A;MEF2D;TRAF6;KAT2B
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.46477275197859186,-1.1201442842771094,0.32339449541284404,0.7625810615367867,1.0,5/14,21.60%,NOX4;AIFM1;CYBB;NOX1;NCF2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.34538371951445207,1.1173160874877002,0.25942350332594233,0.8980243037305474,1.0,75/268,19.83%,FOXO1;FZD6;FZD4;MFHAS1;FBXW7;HIF1A;TNFRSF1B;NFKBIA;PRKAR2B;CASP8;TRAF1;NKD2;TMBIM6;RALB;DTX3L;SMAD7;HERC2;PRR5L;CD40;TRIB3;DNAJA1;ATXN3;SNCAIP;ARRB1;JAK1;UBE2G1;ARRDC1;WRAP53;NEK6;RPL23;IKBKG;SPOPL;RAD18;SMAD5;CXCR4;SUMO2;MC4R;MC1R;RB1;CUL1;RIPK1;GABARAPL1;RELA;PA2G4;HSP90AB1;ASB4;TRIB1;TXNIP;NDUFS2;UBE2K;TRAF6;APC;MID1;UBXN1;BAG4;CHEK2;RPL11;KDM4A;NEDD8;CUL3;YOD1;BAG1;STAT1;USP7;PARP9;RNF40;PRKACB;STAM;CUL2;USP25;BCL10;TSG101;SMAD2;NLK;GPI
prerank,glycine binding (GO:0016594),-0.49557918861513656,-1.1158700473519074,0.3622222222222222,0.767525472780282,1.0,2/11,4.04%,GRIN3A;GLRB
prerank,poly-purine tract binding (GO:0070717),-0.3947443866608959,-1.1155299475760687,0.3085399449035813,0.7613431868403686,1.0,5/27,8.34%,RBMS3;ATXN1;DAZAP1;RBMS1;TIA1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3428166777905121,1.1151367775590422,0.2597984322508399,0.8993669983147716,1.0,63/291,15.69%,RPS6KA5;SNRK;ERN1;ACVRL1;CDK6;INSR;DAPK1;MYH9;PEAK1;PDE2A;PRAG1;PDE4D;MAP4K3;SIK1;STK3;STK4;LMTK2;SYN3;CDC42BPB;MAST2;ATP1A3;ATP1A1;TAP2;MTHFD1L;RAPGEF2;SIK3;ACVR1;FBP1;TSSK6;STK26;MTREX;MLKL;TRIP13;SMARCA5;HASPIN;AKT2;NEK6;PXK;ABCD4;TWF2;ATP7B;AKT3;SIK2;STK38;LONP1;PIM1;ABCD1;MKNK2;HSP90AB1;TOP1;UHMK1;PFKL;TRIB1;MTPAP;ABCG1;EIF2B2;MAP3K20;PMVK;PNPLA8;PANK3;IRAK3;RPS6KA4;MAP4K2
prerank,receptor ligand activity (GO:0048018),-0.2736323164240796,-1.1143921880636387,0.15671641791044777,0.7574776310926322,1.0,44/245,14.21%,BMP6;IGF1;IL34;EPHA7;SEMA3D;PTN;EDA;NBL1;WNT4;BMP5;FGF1;BMP7;IL18;DPP4;SEMA5A;WNT6;BMP4;GREM2;FGF2;WNT9A;IL16;TNFRSF11B;IGF2;NGF;JAG1;SEMA3B;NRG3;OSGIN2;SEMA3A;VEGFB;VEGFA;INHBA;TGFB3;TGFB2;WNT16;FGF7;TAFA2;SEMA6C;GDF11;GDF1;SEMA4B;HBEGF;SEMA3G;IL17D
prerank,cGMP binding (GO:0030553),0.5578573073350777,1.1138990423044663,0.3804347826086957,0.8972529222406138,1.0,3/11,6.12%,PDE2A;CNGB1;RAPGEF2
prerank,phosphatidylglycerol binding (GO:1901611),0.5175155396491907,1.1134084873523085,0.3462214411247803,0.8932782747019629,1.0,6/13,23.71%,PLTP;PITPNC1;PITPNA;OPA1;UQCC3;STOML2
prerank,glucuronosyltransferase activity (GO:0015020),0.48753611929713947,1.1084059581740595,0.35075885328836426,0.9025802494536501,1.0,1/19,0.47%,CSGALNACT1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3939800772297696,1.1077738922606861,0.3096862210095498,0.8988255390173419,1.0,13/73,13.38%,CALCRL;CYSLTR1;NPR1;NLRP6;CX3CR1;HCRTR1;MCHR1;INPP5K;APLNR;MC4R;MC1R;NPFFR1;LTB4R
prerank,nuclear receptor coactivator activity (GO:0030374),0.40448469538156034,1.1056547546477906,0.3008595988538682,0.8999869168611349,1.0,11/52,11.33%,TACC1;CNOT6;ACTN4;ACTN1;PKN1;NCOA1;SS18;RBM14;RNF4;ZMIZ1;ENY2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5175633525612788,1.1005914095448803,0.3733826247689464,0.9095824620672187,1.0,1/12,1.09%,TENT4A
prerank,lipase activator activity (GO:0060229),-0.489751027294133,-1.0999407525192626,0.35172413793103446,0.791861562820927,1.0,1/10,0.11%,ARHGAP6
prerank,DNA polymerase activity (GO:0034061),0.4727250628896642,1.0975410981182894,0.33117932148626816,0.9136569212070997,1.0,3/22,8.30%,POLK;PRIMPOL;POLA1
prerank,rRNA binding (GO:0019843),0.4207111325933984,1.0966614252142106,0.32686567164179103,0.9108534374143381,1.0,16/42,21.26%,RPS14;CAVIN1;RRS1;ANG;RPL23;MRPS18A;NOP53;FASTKD2;RPS13;EMG1;RPL11;PTCD3;MRPL11;RPS3;SBDS;RCC1L
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.4968622705392792,1.096553481622478,0.359106529209622,0.9057254912482372,1.0,8/16,20.08%,MTM1;MTMR6;SYNJ1;INPP5F;MTMR12;MTMR9;MTMR2;SACM1L
prerank,signaling receptor complex adaptor activity (GO:0030159),0.4396243679271645,1.0951227022256607,0.34626865671641793,0.9045975519706665,1.0,5/38,4.22%,SHANK3;NCK1;CARD10;SH2B2;SORBS1
prerank,phospholipase binding (GO:0043274),-0.4668750358444508,-1.0938888402350444,0.36926605504587157,0.8014657383970699,1.0,2/13,1.21%,ARHGAP6;PRKN
prerank,secondary active transmembrane transporter activity (GO:0015291),0.40716662040272467,1.093755026052166,0.34124629080118696,0.9032760461880217,1.0,10/51,10.90%,SLCO2B1;SLCO2A1;SLC25A16;SLC16A2;SLC35E4;CLCN3;ANKH;SLC25A30;SLC35D2;SLCO1B1
prerank,double-stranded RNA binding (GO:0003725),0.3853377381880105,1.0883140120619381,0.33738191632928477,0.9144045385679902,1.0,16/70,13.89%,LRRFIP1;ADARB1;MSN;SLC3A2;ACTN1;MBNL1;DROSHA;DICER1;RFTN1;RC3H1;ADAR;OASL;HSP90AB1;IFIH1;FMR1;DHX15
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.34758359437537534,1.087477032414897,0.32201405152224827,0.9115914442348906,1.0,22/173,10.23%,ELK3;DACH1;PPARD;ZBTB16;ETV6;LRRFIP1;FOXP1;SOX13;HHEX;NR3C1;KLF8;TGIF1;ZFP57;ETS2;TCF3;NFKB1;CREM;FOXK1;BACH1;SP2;SKIL;KLF12
prerank,calcium channel inhibitor activity (GO:0019855),0.5410909626524936,1.0862831583717352,0.39705882352941174,0.9097873933837947,1.0,3/11,16.26%,FKBP1A;MCUB;CALM1
prerank,RNA polymerase binding (GO:0070063),0.492804626209148,1.086270055477865,0.38162544169611307,0.904526814727417,1.0,6/18,16.51%,STOM;PKN2;NEDD4;ZFP36;PHRF1;ANP32B
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.4450553744125984,1.084474813358144,0.3737864077669903,0.9045418739214184,1.0,12/28,23.28%,EDC3;DROSHA;RNASEH2A;NUDT16;DICER1;RPP30;RPP25;ENDOV;PRORP;MRPL44;RNASEH1;DBR1
prerank,phospholipase C activity (GO:0004629),-0.3876830931131095,-1.0838266326683197,0.3641160949868074,0.8237513307027948,1.0,7/25,8.13%,PLCL1;PLCE1;EDNRA;PLCD3;PLCB3;PLCD1;BDKRB2
prerank,deubiquitinase activity (GO:0101005),0.3725518524512125,1.0820802893469446,0.3459037711313394,0.9062583963626917,1.0,11/88,10.53%,USP53;MINDY1;USP3;MINDY2;EIF3H;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.40387830001925407,-1.080739976179977,0.3553921568627451,0.8246445285152655,1.0,12/21,17.12%,AKAP7;AKAP6;ARFGEF2;PRKACA;EZR;AKAP8L;RYR2;WASF3;WASF1;ACBD3;PJA2;PRRC1
prerank,triglyceride lipase activity (GO:0004806),0.47615556148150595,1.0797711277630986,0.37993421052631576,0.9076827785527888,1.0,4/20,18.96%,LIPE;LPL;PNPLA2;CEL
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.5317735309083016,1.0794559672647648,0.3705103969754253,0.9033101868151766,1.0,3/12,1.39%,BMPR2;ENG;ACVRL1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4177124073914006,1.079040944960908,0.37753510140405616,0.8992339927665985,1.0,6/42,4.24%,ESAM;CD200;BSG;ROBO4;TMOD3;PDLIM1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.4049724277124885,-1.0780626018714865,0.3694581280788177,0.8251697876793128,1.0,6/20,16.77%,MOGAT3;LPGAT1;AGPAT4;LCLAT1;LPCAT1;AGPAT3
prerank,cAMP response element binding (GO:0035497),-0.4870026983348402,-1.077692499314203,0.36283185840707965,0.8188871849659776,1.0,4/10,20.05%,CREB5;E4F1;CREB3L1;NR4A3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.37212015238575086,1.0755418745422525,0.35588633288227334,0.904882561595096,1.0,13/78,12.86%,CTSC;CASP4;CASP8;USP15;TINAG;CASP7;CTSK;CTSO;MALT1;CASP1;PIGK;LGMN;CAPN5
prerank,phospholipase A2 activity (GO:0004623),0.45644859588878667,1.0730526207999083,0.38311688311688313,0.9066435948708669,1.0,3/26,8.50%,PLA2G4A;PLA2G2D;PLAAT3
prerank,NADP binding (GO:0050661),0.4336497874900054,1.071347413346426,0.3871473354231975,0.9066407886904305,1.0,3/32,4.11%,NOS3;LBR;CAT
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.48445633102449703,-1.0698050791737266,0.39954853273137697,0.8338626257103499,1.0,4/10,21.60%,NOX4;CYBB;NOX1;NCF2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4443121544538464,1.0682437830035831,0.38041733547351525,0.9105738796357841,1.0,9/28,19.21%,DAB2IP;TRAF1;BABAM2;RIPK1;BID;TRAF6;CASP8AP2;STAT1;MADD
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4879876957704035,1.0660448106436928,0.3979763912310287,0.9119197664489374,1.0,1/16,1.45%,PIR
prerank,steroid hydroxylase activity (GO:0008395),-0.43436089659840305,-1.065861852315245,0.38717339667458434,0.8380736851144277,1.0,3/16,4.73%,CYP7B1;CYP27A1;CYP1B1
prerank,gamma-tubulin binding (GO:0043015),0.46148729955087303,1.063650091890046,0.41968911917098445,0.9138807498875958,1.0,8/21,21.35%,DIXDC1;RAB11FIP5;ARHGEF7;RAD51D;PAK1;CDK5RAP2;GIT1;RACGAP1
prerank,SUMO binding (GO:0032183),0.5030148573409841,1.0635822790357288,0.42066420664206644,0.9091300007898068,1.0,7/13,21.88%,HERC2;RNF4;SERBP1;CASP8AP2;USP25;SIMC1;RNF111
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.41102445141467053,-1.0628048283270206,0.38,0.8396850417768893,1.0,9/21,33.79%,P2RX4;GLRB;GRIK2;CHRNA7;CHRNB2;P2RX5;P2RX7;P2RX3;P2RX6
prerank,tau-protein kinase activity (GO:0050321),0.469683361648796,1.0625960393507432,0.4006677796327212,0.9070461246607199,1.0,5/20,6.69%,FYN;TAOK2;MARK3;SIK3;DYRK1A
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3767159489354087,-1.0609310765992381,0.36578947368421055,0.8379166688265797,1.0,3/27,3.59%,LRP1;HSPG2;SYT1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.399620709580436,-1.0595511892061507,0.4119106699751861,0.834584911424382,1.0,11/22,29.17%,SCN7A;CACNA1G;SCN2B;SCN1A;SCN8A;SCN2A;SCN1B;SCN5A;SCN9A;CACNA1H;HCN4
prerank,CoA-ligase activity (GO:0016405),-0.4360341962093114,-1.0592446209949846,0.37122969837587005,0.8283785653975134,1.0,4/14,20.86%,ACSL1;AACS;ACSS2;ACSBG1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4227856944194425,1.0545717252270448,0.39164086687306504,0.9253956345158841,1.0,4/34,2.10%,ARAP3;PARD3;HIP1R;IQGAP1
prerank,sulfotransferase activity (GO:0008146),-0.3641626507272918,-1.052395309036973,0.38133333333333336,0.8416921968389239,1.0,7/33,10.63%,UST;HS3ST3A1;CHST15;TPST1;HS2ST1;CHST3;HS6ST1
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.33125969501817504,-1.0514750229291936,0.34576271186440677,0.8373759408420594,1.0,11/49,14.88%,ATP1A2;MPPED2;PXYLP1;DUSP11;EPHX2;LHPP;DUSP10;PTPN22;SBF1;PPP1CB;ACP6
prerank,cysteine-type peptidase activity (GO:0008234),0.370043796058006,1.0480814821501594,0.3806179775280899,0.9391229772950527,1.0,10/73,8.27%,CTSC;CASP4;CASP8;USP15;TINAG;CASP7;CTSK;CTSO;MALT1;CASP1
prerank,heme binding (GO:0020037),0.37991141877570167,1.046781186521583,0.39330543933054396,0.9379645248811608,1.0,6/65,5.93%,NOS3;PTGS2;PXDN;CYP26A1;CAT;CYCS
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.42134406323404094,1.046537621455954,0.4024767801857585,0.9337640145384942,1.0,13/33,22.17%,CNOT6;CNOT6L;ISG20;ANGEL2;REXO2;DCP2;CNOT7;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.45500427857824394,1.045928633183544,0.42244224422442245,0.9305280823569894,1.0,4/23,3.84%,PLCB4;PLCG1;PLCB1;PLCG2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3717984670385133,1.0454062576491692,0.38140161725067384,0.9271283600930934,1.0,9/72,4.85%,FLII;PARD3;HIP1;HIP1R;KCNQ1;PLCB1;FCHO2;TIRAP;SDCBP
prerank,metalloexopeptidase activity (GO:0008235),-0.3233148631317027,-1.0442606464600235,0.3734567901234568,0.8513172651098807,1.0,8/51,8.95%,AEBP1;CPQ;MMP14;MMP16;NPEPPS;ENPEP;CPXM2;CPXM1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4915663298243767,1.0435124284293589,0.4295774647887324,0.9275986220035286,1.0,3/13,4.17%,KCNQ1;PRKAR2B;SOX9
prerank,calcium activated cation channel activity (GO:0005227),-0.40800647359740255,-1.0433226079872846,0.38333333333333336,0.8471326490475922,1.0,5/17,14.24%,KCNMA1;ANO1;KCNMB2;TMEM63A;KCNN2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5119551050473174,1.0407470932463292,0.42385321100917434,0.9304732963084902,1.0,1/11,2.28%,PPP1R2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5091802967224931,1.0399743616221204,0.4509466437177281,0.9278639268799553,1.0,4/10,17.35%,ATXN3;OTUD4;YOD1;DESI2
prerank,calcium-activated potassium channel activity (GO:0015269),-0.45255303591744833,-1.0394851532223035,0.4321266968325792,0.8510044180951774,1.0,5/11,20.12%,KCNMA1;KCNMB2;KCNN2;KCNN3;KCNU1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.406692243531536,1.0382443719549657,0.41781874039938555,0.9280327528536331,1.0,9/37,17.58%,GARS1;FARS2;IARS1;TARS3;LARS1;WARS1;RARS1;KARS1;WARS2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.486678791263325,1.0368767592475054,0.429097605893186,0.9273127374549367,1.0,5/13,18.06%,SH3BP4;CCDC88A;GDI2;EIF5;ARHGDIA
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5026369448839005,1.0350872178552641,0.4375,0.9275330825476563,1.0,2/11,7.06%,KCNQ1;KCNE2
prerank,voltage-gated ion channel activity (GO:0005244),0.48575171450264854,1.0343882576719592,0.43562610229276894,0.9248557900042035,1.0,4/14,10.58%,CACNA1E;PKD2;VDAC3;ANO6
prerank,myosin II binding (GO:0045159),0.5220370470639895,1.033442061516335,0.47126436781609193,0.9228644583026523,1.0,3/10,8.82%,SHROOM4;SHROOM1;LLGL1
prerank,Notch binding (GO:0005112),-0.38222652757182485,-1.0332248385741456,0.40691489361702127,0.862027588137412,1.0,5/22,7.80%,SNED1;AAK1;JAG1;CCN3;DTX1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.36356969283507407,1.0327693482180376,0.3895747599451303,0.9200832780067683,1.0,8/70,8.79%,CSGALNACT1;LFNG;MGAT4A;MFNG;B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,diacylglycerol kinase activity (GO:0004143),0.5068423063174944,1.0320259966453138,0.4416826003824092,0.9176609621124509,1.0,3/11,11.26%,DGKZ;DGKH;DGKE
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.4134381872177068,-1.0316805234249051,0.42748091603053434,0.8526708137813582,1.0,5/17,10.27%,EPHA3;EPHA7;EPHA8;EPHA6;EPHA10
prerank,ephrin receptor activity (GO:0005003),-0.4134381872177068,-1.0316805234249051,0.42748091603053434,0.8526708137813582,1.0,5/17,10.27%,EPHA3;EPHA7;EPHA8;EPHA6;EPHA10
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4422939563752961,1.0292605647709616,0.45346869712351945,0.9208010606449453,1.0,8/22,21.31%,PPM1F;DUSP23;DUSP16;DUSP7;DUSP2;DUSP19;MTMR2;DUSP18
prerank,NF-kappaB binding (GO:0051059),0.4437049150942515,1.0290857532569662,0.4457627118644068,0.9168034840836874,1.0,6/24,14.04%,NFKBIA;TAF4B;PSMA6;RELA;RNF25;NPM1
prerank,cation transmembrane transporter activity (GO:0008324),-0.3200738905276819,-1.0289366681711964,0.4034090909090909,0.8535827206739964,1.0,5/48,3.53%,SLC7A2;SLC41A1;SLC1A5;SLC6A9;SFXN2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3406717801751876,-1.0284944948744674,0.37669376693766937,0.8481098510479758,1.0,10/33,19.54%,AR;RECQL5;CTR9;PAF1;ERCC5;DRAP1;WDR43;HNRNPU;UVSSA;ELP4
prerank,I-SMAD binding (GO:0070411),0.48439638572761623,1.02795496909274,0.46524064171123,0.9154751453542772,1.0,4/13,10.28%,SMAD1;SMURF1;SMAD7;SMAD5
prerank,histone acetyltransferase binding (GO:0035035),0.44186505336253656,1.0248994508462892,0.451505016722408,0.9191712507874478,1.0,3/21,5.41%,EPAS1;HIF1A;TRIM68
prerank,5'-3' exonuclease activity (GO:0008409),0.4828311474678161,1.0234932402776087,0.44543828264758495,0.9184472107130135,1.0,5/14,18.05%,FAN1;DCP2;TRIR;XRN2;DCLRE1C
prerank,anion channel activity (GO:0005253),0.36728543883952525,1.020842573648812,0.4340425531914894,0.9213108685206055,1.0,8/61,10.73%,LRRC8C;ANO2;LRRC8B;BEST1;CLCN3;VDAC3;ANO6;GABRD
prerank,protein phosphatase activator activity (GO:0072542),0.4824283551015089,1.020648752730991,0.45321100917431195,0.9174451508925665,1.0,3/13,8.37%,PPP2R5A;PPP2R5E;PPP2R5B
prerank,DNA replication origin binding (GO:0003688),0.4345638935311449,1.0194580948197536,0.43471074380165287,0.9163214161059337,1.0,6/23,16.14%,MCM10;POLA1;MCM9;GRWD1;ORC5;ORC3
prerank,transition metal ion binding (GO:0046914),0.3070390501902964,1.0183840269692868,0.45,0.9147636414013077,1.0,59/397,13.80%,MYRIP;SHANK3;NOS3;TNFSF10;RNF125;GCH1;MSRB3;ARHGEF2;PDE2A;GDA;SAMHD1;KLF7;KDM3A;TES;LCN2;TET3;ENPP2;ASAH2;MYCBP2;PAM;ABO;EEA1;ADAMDEC1;RNF7;SIRT5;ERAP1;KDM4C;PRIMPOL;ZNF2;TRIM24;PGGT1B;ANG;NUDT16;PTPN1;AFM;SIAH1;ATP7B;CYP2R1;RC3H1;RPS27;ABL2;ZMYND11;PITRM1;RNF112;PIM1;PRDM2;ADH1A;MGAT5;ETHE1;SIRT6;TET2;SORD;TMEM163;AOC1;IFIH1;ACR;MTPAP;RPS29;SOD2
prerank,thyroid hormone receptor binding (GO:0046966),0.41218183368033107,1.018183915281319,0.449685534591195,0.91092740958007,1.0,8/28,22.79%,TACC1;JMJD1C;OASL;GTF2H1;TAF7;GAS2L1;MED12;MED17
prerank,voltage-gated potassium channel activity (GO:0005249),-0.28795269795322775,-1.0176115922516278,0.3984375,0.8718955569724585,1.0,23/80,18.87%,KCNK2;KCNB2;KCNMA1;KCNQ3;KCND2;KCND3;KCNC2;KCNS3;KCNJ2;KCNQ4;KCNJ13;KCNQ5;KCNA6;KCNJ10;KCNT1;KCNN2;KCNJ8;KCNJ15;LRRC38;KCNJ6;KCNE4;KCNN3;KCND1
prerank,protein heterodimerization activity (GO:0046982),0.3231395302883349,1.0172620811154334,0.4404332129963899,0.9090489011152479,1.0,23/178,8.26%,EPAS1;ZHX3;RALGAPA2;MEF2C;AHR;PDGFB;HIP1;FZD4;HIF1A;RALGAPA1;KCNB1;ADRB1;IKBKB;SDCBP;XBP1;TCF4;ATP1A1;BOK;AURKA;ITGA3;TCF3;MICU2;NEUROD1
prerank,neurexin family protein binding (GO:0042043),-0.4582051759158775,-1.016701654991688,0.4358974358974359,0.867809403785252,1.0,5/10,10.58%,NLGN2;NLGN1;SYTL2;SYTL5;NLGN3
prerank,mRNA 5'-UTR binding (GO:0048027),0.4376684733896978,1.016154659841704,0.4377952755905512,0.907495898885897,1.0,10/24,26.36%,IGF2BP3;RPS14;RPS7;FMR1;RPS13;DHX36;RPL26;MRPS11;RPL41;SYNCRIP
prerank,amino acid binding (GO:0016597),0.41242437733799286,1.0089156063417009,0.4423963133640553,0.9218917199658836,1.0,2/31,4.82%,NOS3;PADI4
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3578232930650569,-1.0087050846457775,0.4343163538873995,0.8837798698302874,1.0,7/27,7.88%,SLC26A7;SLC22A8;SLC26A2;ANO1;SLC22A6;SLC39A14;SLC5A5
prerank,kinase activity (GO:0016301),0.3368444620100971,1.0075967983005423,0.4549019607843137,0.9209912418905302,1.0,26/109,18.35%,PRKD1;DGKZ;LYN;PRKD3;PIK3C2A;PKN2;DGKH;ITPKB;TRIB3;PIK3CG;CERKL;PANK2;NMRK1;EPHA4;GK5;DGKE;IDNK;CHKA;PMVK;RFK;PANK3;PAPSS1;DOLK;IPMK;CSNK2A1;PIK3C2B
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.4507140418415689,-1.0068357950021174,0.4840764331210191,0.8825539191274767,1.0,8/11,36.71%,NDUFAF7;CARM1;PRMT9;PRMT8;PRMT2;PRMT7;PRMT6;PRMT1
prerank,calcium ion binding (GO:0005509),-0.24373297116389603,-1.0054890091633664,0.36585365853658536,0.8798450943887162,1.0,52/323,11.30%,LRP1;FBN1;GSN;CDH11;FBLN1;ENPP1;ADGRV1;SPARC;CLEC3B;KCNIP4;ANXA5;SLC8A1;CDH13;THBS1;GJB2;SYT1;ASPH;SMOC2;C2CD5;CDH1;SCUBE1;S100A6;AMY1A;AMY1B;AMY1C;ANXA1;PCLO;NRXN1;RASGRP2;RCN3;THBS3;STIM1;SYT9;PLSCR2;SYT12;SYT11;ANXA2;ASPN;S100B;ANXA6;PITPNM3;ATP2A2;RCN1;ENPP3;ANXA3;RYR2;SLC25A12;TKT;S100A10;SLIT2;ANXA4;MICU1
prerank,pyrophosphatase activity (GO:0016462),0.3761764435363481,1.0044395594256825,0.4479166666666667,0.9252647606665007,1.0,14/50,19.51%,ENTPD1;PLPP1;BNIP2;NUDT16;RNGTT;PRUNE1;DCP2;NUDT15;NUDT14;PLPP5;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,serine-type endopeptidase activity (GO:0004252),-0.2858456873562872,-1.0009253134213247,0.44106463878326996,0.8856974013654105,1.0,9/80,9.22%,F3;RHBDL3;DPP4;PCSK5;FAP;KLK2;PLAT;RHBDF1;MMP2
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.30261268278799036,-0.9995560462578417,0.4605678233438486,0.8830498942963964,1.0,7/53,6.15%,MICAL3;MICAL2;DDO;AOX1;DPYD;NOX4;PRODH
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.4229418236160556,0.9990067107481772,0.4605263157894737,0.9349200456771362,1.0,4/23,7.56%,HIP1;HIP1R;PLEKHA5;SNX3
prerank,MHC class II protein complex binding (GO:0023026),-0.44045804523995324,-0.9986183838376969,0.4756380510440835,0.879275251486717,1.0,3/11,11.16%,ATP1B1;HSP90AA1;CD81
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3360275700711927,-0.997575969834004,0.4747191011235955,0.8757677363983514,1.0,9/35,11.39%,PLCL1;MPPED2;PLCE1;ENPP1;PLCB3;ENPP3;TDP2;SMPD3;SMPD4
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.4766457883577928,0.9975221860370695,0.48333333333333334,0.9344780983362863,1.0,2/13,10.54%,ECI1;ECH1
prerank,retinoic acid binding (GO:0001972),0.4810708073473102,0.9965130748398535,0.4528301886792453,0.9329105082705005,1.0,2/12,6.57%,CYP26A1;CYP26C1
prerank,phosphatase inhibitor activity (GO:0019212),0.4452518331082382,0.9961400255892366,0.467687074829932,0.9296590626170974,1.0,5/20,15.04%,PPP1R2;PPP1R9B;LMTK2;MGAT5;STYX
prerank,MAP-kinase scaffold activity (GO:0005078),-0.4497598778771294,-0.9958094809774813,0.4947589098532495,0.8740123898579533,1.0,3/11,2.92%,AKAP13;SH3RF1;KSR1
prerank,titin binding (GO:0031432),-0.4226915893970553,-0.9943293967235336,0.5134529147982063,0.8719933084659459,1.0,2/13,10.96%,ACTN2;TRIM63
prerank,cell adhesion mediator activity (GO:0098631),0.4221030937758875,0.9906225434645395,0.46921797004991683,0.9399604231472496,1.0,5/24,9.25%,ESAM;BSG;ROBO4;BCAM;DSCAM
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.41489007957901824,0.9899142238982107,0.48183254344391785,0.9376060996956458,1.0,4/26,8.79%,CSGALNACT1;B3GNT3;B3GNT4;B3GNT6
prerank,thioesterase binding (GO:0031996),0.4841072186393176,0.9889772048214688,0.5063752276867031,0.9358654706039168,1.0,3/11,14.18%,TRAF1;RAC1;TRAF6
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4555142641875311,0.9887318491615172,0.4897260273972603,0.9323661455266496,1.0,6/14,19.93%,MTM1;MTMR6;SYNJ1;MTMR12;MTMR9;MTMR2
prerank,fibroblast growth factor binding (GO:0017134),-0.37093117823025545,-0.9875775560895785,0.476303317535545,0.884154616833447,1.0,4/21,10.72%,FGFR2;THBS1;ITGAV;FGFR4
prerank,iron ion binding (GO:0005506),-0.31676663405656447,-0.9865314322414336,0.4831081081081081,0.8805122228323521,1.0,13/48,20.30%,AGMO;AOX1;KDM7A;TET1;EGLN3;FDX1;SCD;FTO;SNCA;ACO2;NFU1;ABCE1;SCD5
prerank,syntaxin-1 binding (GO:0017075),0.4291375446355913,0.9861303063104989,0.4784110535405872,0.9348019565112706,1.0,3/22,4.38%,UNC13B;DAPK1;SYPL1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.4473958165954668,-0.9848307471624743,0.49888641425389757,0.8788152115057546,1.0,5/10,24.92%,NAA40;BRCA2;KAT8;NAA60;USP22
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.44082309790396224,-0.9804453507771306,0.4897959183673469,0.8844633350439844,1.0,4/11,18.55%,AMFR;UBE4B;UBE4A;UBR5
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.4154055584942827,0.9798078887004433,0.5039370078740157,0.9470156540722025,1.0,3/25,2.00%,ARAP3;HIP1;HIP1R
prerank,lipid phosphatase activity (GO:0042577),0.46481869268477904,0.9794916457766871,0.48128342245989303,0.943723550540472,1.0,3/14,6.60%,PLPP1;SGPP2;INPP5K
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4384622297530647,-0.978149315587394,0.4957081545064378,0.8846726194466178,1.0,3/10,12.49%,KDM7A;KDM2A;KDM8
prerank,sodium channel activity (GO:0005272),-0.3231625454025737,-0.9777901602876455,0.5094850948509485,0.8794301976579632,1.0,15/37,29.17%,SCN7A;CACNA1G;GRIK4;GRIK2;GRIK5;GRIK1;SCN1A;SCN8A;SCN2A;SCN1B;SCN5A;SCN9A;CACNA1H;SCNN1A;HCN4
prerank,copper ion binding (GO:0005507),-0.3132254097323584,-0.9774838037763561,0.5042016806722689,0.8743484952881982,1.0,10/42,18.33%,MOXD1;P2RX4;LOXL3;SOD3;LACC1;CCS;SNCA;GPC1;MT3;COX17
prerank,MAP kinase activity (GO:0004707),-0.3960641456726454,-0.9749182320047408,0.4988009592326139,0.8750521706565748,1.0,2/14,7.31%,MAPK4;MAPK10
prerank,ATPase binding (GO:0051117),0.3430377113861533,0.9748394256034475,0.48633879781420764,0.9511543070841137,1.0,15/71,9.23%,CAV1;ESR1;PPP3CA;PDE4D;NKD2;RALB;ATXN3;ATP1B3;LCK;ATP6V0A1;PKD2;PSEN1;PEX26;CHMP4A;ANK1
prerank,PDZ domain binding (GO:0030165),0.3536795095680393,0.9727402478362728,0.5014005602240896,0.9523417914926989,1.0,11/61,6.54%,CADM1;F11R;USHBP1;FZD4;SNTG2;DOCK4;ADRB1;CLCN3;ATP2B4;RAPGEF2;TMEM88
prerank,cAMP binding (GO:0030552),0.4800421369046459,0.9724122814646095,0.5110294117647058,0.9489960333258363,1.0,3/11,6.12%,PDE2A;PDE4D;RAPGEF2
prerank,chemokine binding (GO:0019956),-0.34275366619570075,-0.9706100323771412,0.4985835694050991,0.8807056190662768,1.0,4/30,5.58%,PDPN;CCR9;FGF2;ITGAV
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.38856955648808655,-0.9704179447745866,0.502127659574468,0.8754070572135049,1.0,6/16,30.95%,SLC22A4;SLC25A42;SLC22A2;SLC22A3;SLC5A7;SLC29A4
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3436653291800813,0.970031445932699,0.500697350069735,0.9510643218422133,1.0,16/69,15.79%,PLA2G4A;CERS4;LPCAT3;GLYAT;SOAT2;ZDHHC18;PLAAT3;KAT6B;ZDHHC9;HHAT;MOGAT1;KAT2B;DGAT1;KAT6A;NAA16;MOGAT2
prerank,actinin binding (GO:0042805),-0.3716423090623231,-0.9694735621925729,0.5025380710659898,0.8721401049027714,1.0,3/21,3.02%,CACNA1C;CACNA1D;DAG1
prerank,kinase activator activity (GO:0019209),-0.33208425560994803,-0.9675319022566925,0.4861878453038674,0.8716493950924773,1.0,15/30,28.02%,GPRC5C;PRKAG2;SPDYA;STRADA;RGCC;WNK1;GPRC5B;WNT11;MT3;AGAP2;GPRC5A;TPX2;EPO;TREM2;FGF13
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3833775459389537,-0.9655921148202463,0.5090497737556561,0.8708149397679024,1.0,8/17,24.59%,DPYD;TECR;BDH2;MECR;DECR1;DHCR24;DHCR7;PECR
prerank,kinesin binding (GO:0019894),-0.3488492105666249,-0.965264352676681,0.5180412371134021,0.8659807837528939,1.0,16/27,30.99%,ARHGEF10;IFT88;PLEKHM2;RAB29;KIF1B;TTBK2;KIFAP3;SNCA;PRC1;KLC2;KIF18B;TOR1B;TOR1A;CROCC;NEFH;FAM83D
prerank,lysophospholipase activity (GO:0004622),0.4273991324533413,0.9637104297169934,0.5111111111111111,0.962635093004274,1.0,4/20,14.60%,PLA2G4A;ENPP2;GDPD1;PNPLA6
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4440452383952245,0.9633169229467375,0.5296167247386759,0.9595355631680369,1.0,5/18,7.33%,ENG;FKBP1A;SMAD7;USP15;TGFB1
prerank,ubiquitin protein ligase activity (GO:0061630),0.2983715021660359,0.962515856261699,0.5300113250283126,0.9573754232147272,1.0,51/228,16.73%,RNF125;SMURF1;RNF144B;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;HERC2;TRIM68;PELI1;XIAP;MYCBP2;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;RNF167;NEDD4;TRIM25;RNF139;UBR1;TRIM24;NEURL3;NEURL1B;SIAH1;UBE2D3;RC3H1;CBL;UBE3A;RNF112;HECTD1;COP1;MYLIP;BIRC3;RNF25;RNF215;UBE2K;TRAF6;TOPORS;MSL2;ARIH2;RNF5;UBE3D;AREL1;BIRC2;NHLRC1
prerank,hyaluronic acid binding (GO:0005540),0.47824273373462517,0.961653498338085,0.5054347826086957,0.9553647344942887,1.0,1/10,1.12%,LAYN
prerank,endopeptidase regulator activity (GO:0061135),-0.3131034778103881,-0.9608592579710413,0.5201149425287356,0.8712521815818557,1.0,7/40,11.32%,TFPI;ITIH2;RENBP;RECK;SERPIND1;APH1B;CST3
prerank,nucleotidyltransferase activity (GO:0016779),0.42768290447369073,0.9605011483041711,0.5281090289608177,0.9542762472584827,1.0,6/19,19.06%,TENT4A;CGAS;MTPAP;PNPT1;PAPSS1;YRDC
prerank,hydro-lyase activity (GO:0016836),-0.31097933555983365,-0.9591076239017844,0.5303867403314917,0.8700993732796294,1.0,13/41,16.40%,GMDS;HACD3;ECHDC1;ENO2;CA4;HACD1;ECHDC3;ECHDC2;L3HYPDH;CBS;NAXD;ENO3;ACO2
prerank,adenylyltransferase activity (GO:0070566),0.4153526039911522,0.958357158310412,0.5062166962699822,0.9556494356320744,1.0,5/21,15.50%,TENT4A;GPHN;OASL;MTPAP;KARS1
prerank,U6 snRNA binding (GO:0017070),0.45164760885936217,0.9569319569296194,0.5244360902255639,0.9549446199681012,1.0,9/14,27.00%,LSM8;LSM3;LSM7;PRPF4;SART3;EIF5A;LSM2;TUT1;METTL16
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3783825148191938,0.9567636032922933,0.5306748466257669,0.9513148701563838,1.0,4/34,4.49%,IQGAP1;CCNK;STK3;STK4
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.47070866011442525,0.9561597158957568,0.5203883495145631,0.9488621169788007,1.0,2/10,7.41%,PIK3C2A;PIK3CG
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.32576363179297996,0.9554986953905166,0.5116883116883116,0.9464379640176069,1.0,11/91,7.56%,FLII;PARD3;HIP1;HIP1R;KCNQ1;PLCB1;FCHO2;TIRAP;SDCBP;PLEKHA5;SNX3
prerank,carboxy-lyase activity (GO:0016831),-0.3470229952042149,-0.9551165887546238,0.5073529411764706,0.8743888780535545,1.0,6/23,20.25%,ECHDC1;GGCX;ODC1;AZIN1;PCK2;DDC
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.38807811457961894,0.9529575659261855,0.5138888888888888,0.948599353898507,1.0,4/29,11.52%,ACER2;CTBS;PARG;OVGP1
prerank,ADP binding (GO:0043531),0.40406916090658523,0.9516184232995673,0.52,0.9481261370548304,1.0,5/25,13.77%,ERN1;MYH9;LONP1;ABCD1;ABCG1
prerank,chemoattractant activity (GO:0042056),0.3974538416036444,0.9504049398257335,0.5349593495934959,0.9472821731911955,1.0,3/26,5.08%,PDGFB;VEGFC;VEGFD
prerank,transaminase activity (GO:0008483),-0.42131773396526134,-0.9488399110049283,0.5454545454545454,0.8847467005988461,1.0,3/11,12.73%,ABAT;GOT1;OAT
prerank,RNA binding (GO:0003723),0.27643457472481775,0.9481710994617428,0.6926926926926927,0.9488093967842469,1.0,471/1321,26.43%,NANOS3;SORBS2;NOVA2;PRPF38B;RBPMS;SPTBN1;FLNB;LRRFIP1;ADARB1;MYH9;FASN;STAT3;ANP32A;SAMHD1;MSN;DHX40;SNTB2;SLC3A2;LBR;ACTN4;DDX54;RPS15;TMSB4X;PKN2;TES;ACTN1;IGF2BP3;IMP3;RPS19;RPS14;RBM20;MBNL1;PTBP3;RPSA;MBNL2;RPS16;CAVIN1;RPL38;NANOS2;FARS2;EIF4E;N4BP1;CTNNA1;EDC3;EIF3H;UCHL5;RPL34;RPS20;RPL39;DROSHA;PPP1R10;HNRNPF;CNBP;SF3B4;RPS7;UBAP2;NXF2;MBNL3;SYNE1;RPS24;TASOR;ZNFX1;SEC63;HNRNPA0;MTREX;HNRNPK;FCF1;RBM14;NOSIP;RPL37A;GTF2E2;ZNF326;SRBD1;ASCC3;HNRNPD;WRAP53;RPF1;RPL36;TRIM25;EIF1;EIF1AX;RPS18;WDR33;SPATS2;SAMSN1;RSL24D1;DDX50;RPL15;NELFE;DYNC1LI1;RBM25;PHF6;RRS1;SUCLG1;GLRX3;ANG;PINX1;THOC2;NAP1L4;RPS8;KHNYN;NPM3;MYBBP1A;LSM8;RPL14;SUB1;YBX3;GDI2;RPL23;RPL17;DUT;NUDT16;CHD2;TBCA;NIFK;DNTTIP2;PTRH1;PTPN1;DICER1;G3BP1;PUM1;RFTN1;HELZ;HNRNPLL;SMG7;RPL9;SERBP1;RPL4;TWF2;RPL13A;RBM18;CNOT1;HELB;RPS11;RPL32;PSMA6;OTUD4;RBM3;SUMO2;FSCN1;YTHDC1;RC3H1;PPHLN1;RPL22;SPEN;RBM15;RPS27;DRG2;RPL31;RPS23;KCTD12;TFB2M;RO60;EXOSC1;CFAP65;ADAR;DDX51;DCP2;RNPS1;MRPL13;RPL13;LSM3;MRPS12;RPS12;PUM2;SRP9;LONP1;RPP30;NUP98;FAU;EIF5B;PEBP1;APEH;OASL;RPP25;NOP53;UTP4;RSRC2;HNRNPC;PA2G4;RPL6;ZFP36;RPL10;RACK1;FASTKD2;RTCB;EIF2AK4;RNMT;SLTM;HSP90AB1;TOP1;NOP16;FBLL1;BTF3;MRPL41;IFIH1;NOL10;GRWD1;FMR1;MTPAP;RPS6;POLR1G;CAST;SF3B6;DHX15;R3HDM1;NPM1;FBRSL1;QKI;SCAF11;MAP3K20;RPL29;ZC3H12C;RRP9;MRPL4;LARP4B;ADAT1;PELP1;RPS25;SRFBP1;YY1;NSRP1;RPL35A;RPS13;RPS21;SNW1;RPL27;RPL18;XRN2;AIMP1;ENDOV;MRPL23;RPL7L1;TPT1;EMG1;RPL27A;LSM14A;YBX1;YLPM1;NELFCD;MRPS5;RRP1B;KARS1;ZCCHC17;AQR;CEBPZ;RBM42;RPS10;RDX;DDX20;G3BP2;EIF5;BAG4;LUC7L2;UTP6;HNRNPUL1;MRPL37;CWC22;AGFG1;PNPT1;ZC3H4;ANXA11;VIRMA;ZFP36L1;PDCD11;TRMT6;MAK16;PRDX1;RPL11;ALYREF;XPOT;UBE2I;CDC40;CSDE1;HEATR1;LSM7;ESF1;PRPF40A;RPL8;PHF5A;EEF2;NOP14;PTCD3;ZCCHC7;MRPL11;HELZ2;PRKRIP1;METTL14;GRB2;RALY;HSPE1;DIAPH1;LARP4;TXN;RPL18A;HNRNPM;BST2;CISD2;HMGN5;MRPL54;KDM1A;PPP1CC;STRAP;NUDT1;MRPS9;DHX34;DHX36;YRDC;HNRNPAB;CPNE3;SRSF10;FUS;EIF2AK2;BCCIP;MEX3C;ZNF638;HDGF;NOM1;THOC5;ERH;RPL21;LSM1;MRPL43;MRPS26;SART1;RPL3;CCDC47;DAZL;GNL2;MRPL12;SART3;MRPL44;RPS3;DEK;UBE2L3;PURA;PPIB;SBDS;ELAVL1;PEF1;ZCCHC3;RPS28;DDX47;NOL4;SETX;RPN1;DENR;RCC1L;TAF15;PRKRA;KPNB1;URB1;RPL7;RNASEH1;SF3A2;CPSF6;JMJD6;TOE1;RIDA;CCDC9B;LUC7L;TCOF1;ZC3H14;RTF1;MRPS30;THUMPD1;GCN1;NOCT;CDK11B;TRNAU1AP;NOA1;PRPF3;RPL26;EIF4ENIF1;PURB;HMGB1;RTRAF;LACTB2;MRPL1;JUN;RBM7;NGDN;PIN4;NOL6;TRA2B;PPIA;DBR1;SRP19;RARS2;SNRPD3;EIF4E2;YWHAE;SND1;FUBP1;RPUSD2;NSUN6;MAP4;PUS7;FKBP4;SRSF4;ALKBH8;RRP12;DCP1B;SMG6;DNAJC2;RBM33;PPIG;PCDHGA9;NUP42;MRPL39;EIF5A;TENT4B;DDX28;PSPC1;MKRN2;LAS1L;LYAR;EIF3G;EIF4H;ZFR;CPSF2;SYF2;MRPL32;MRPL14;SECISBP2L;MRPS11;MRPL9;LSM2;HNRNPA3;PNO1;AARS2;MTIF2;PCF11;SNUPN;DIDO1;ISG20L2;RBMX;DDX6;SNRNP200;SUMO1;DAP3;NOLC1;ADK;PCID2;MRPL15;RCC2;LARP1B;CPSF3;PUF60;PABPC1L;RPS17;PABPC4L;MRPL42;GSPT2;PRPF40B;ISY1;GFM1;RPL28;WDR46;TRMT10C;UBE2N;DDX60;TCF20;RPL41;NCOA5;RP9;SYNCRIP;RPS2;EDF1;GTPBP4;ACAA2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.35826178957280896,0.9475162152393769,0.5288035450516987,0.9465760915320294,1.0,4/49,3.38%,MCTP1;PLA2G4A;CPNE8;ESYT2
prerank,alpha-tubulin binding (GO:0043014),0.38654450357337533,0.9473431558099601,0.5310015898251192,0.9431903040829399,1.0,5/31,10.10%,FYN;DIP2B;TTLL7;TRPV4;ARL8B
prerank,thiol-dependent deubiquitinase (GO:0004843),0.32698861242002814,0.9458566747658053,0.5363636363636364,0.9429006795946409,1.0,16/83,19.17%,USP53;USP3;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4;USP12;OTULIN;YOD1;USP8;DESI2;USP7;USP25;USP21
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4319330638208134,0.944920785498464,0.5364120781527532,0.9414242861327,1.0,3/15,7.56%,PLA2G4A;PLEKHA5;SNX3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.39064265717361557,-0.9420388272721174,0.5352798053527981,0.8969768422436348,1.0,2/14,3.03%,SLC26A7;SLC26A2
prerank,protein kinase regulator activity (GO:0019887),-0.259613008073835,-0.9410189158032514,0.648068669527897,0.8939610127054726,1.0,30/95,19.54%,PARVA;TAOK3;GPRC5C;CCND2;DNAJC3;PRKAG2;KIDINS220;SPDYA;CCNL2;STRADA;PRKAR1B;RGCC;WNK1;PRKAG3;CCNL1;GPRC5B;PRKAR1A;CDKN1A;CCNT2;CCNG2;SMCR8;WNT11;SNCA;CDKN1C;MT3;PRKAG1;DUS2;CSNK2B;CCNF;ELP4
prerank,galactosyltransferase activity (GO:0008378),0.4658571377215992,0.9401360541435434,0.5642361111111112,0.9493191605115863,1.0,4/11,10.66%,B4GALT4;B4GALT5;B3GNT6;A4GALT
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.40084418106352615,0.9399398949067925,0.533442088091354,0.9459249413220632,1.0,5/24,12.04%,DAPK1;PTK2B;MAPKAPK3;EEF2K;MKNK2
prerank,syntaxin binding (GO:0019905),0.33999872160952566,0.939560758833251,0.5652173913043478,0.9429440498401602,1.0,11/61,12.81%,UNC13B;DAPK1;RAB11A;SYPL1;STX6;STX7;CACNA1A;SNAP23;VAMP8;STX8;STXBP3
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2921185874468279,0.9393382177811597,0.6015981735159818,0.9397078939600412,1.0,50/232,16.73%,RNF125;SMURF1;RNF144B;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;HERC2;TRIM68;PELI1;XIAP;MYCBP2;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;RNF167;NEDD4;TRIM25;RNF139;UBR1;TRIM24;NEURL3;NEURL1B;SIAH1;UBE2D3;RC3H1;CBL;UBE3A;RNF112;HECTD1;COP1;MYLIP;BIRC3;RNF25;RNF215;TRAF6;TOPORS;MSL2;ARIH2;RNF5;UBE3D;AREL1;BIRC2;NHLRC1
prerank,ion gated channel activity (GO:0022839),0.39429024036938964,0.9388000440604701,0.5384615384615384,0.9372091498085826,1.0,4/24,10.58%,ANO2;TTYH2;NMUR2;ANO6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.4556382423153991,0.9381349539635879,0.527681660899654,0.9349092364084236,1.0,2/11,12.99%,PADI4;PADI1
prerank,active ion transmembrane transporter activity (GO:0022853),0.37239293729580514,0.9373096099324023,0.5234375,0.9331745324040776,1.0,2/37,1.65%,SLCO2B1;SLCO2A1
prerank,telomerase RNA binding (GO:0070034),0.404818485428552,0.9368123536481426,0.5437710437710438,0.9307033158157659,1.0,9/22,24.34%,WRAP53;PINX1;SMG7;DCP2;HNRNPC;DHX36;SNRPD3;SMG6;TENT4B
prerank,poly(A) binding (GO:0008143),-0.35608176409615927,-0.9357730017838193,0.5394736842105263,0.9020642082423633,1.0,5/21,15.51%,RBMS3;RBMS1;TIA1;HNRNPU;ELAVL4
prerank,G protein-coupled receptor binding (GO:0001664),-0.24709788743164976,-0.9353086691201163,0.6303317535545023,0.8976565039397774,1.0,28/132,15.84%,WNT4;PRKN;GRK3;RNF43;BICD1;WNT6;TULP3;GNAO1;WNT9A;GNAS;RYK;AGTR1;LRP6;GPRASP2;GNAI1;SFRP1;CXCL12;USP33;FZD1;GPRC5B;WNT16;FZD7;S1PR2;GNA14;ARHGEF11;WNT11;PTCH2;DVL1
prerank,O-acyltransferase activity (GO:0008374),0.39141624449286266,0.9350292369319673,0.540625,0.931116442905022,1.0,7/30,15.79%,PLA2G4A;LPCAT3;SOAT2;MBOAT1;MOGAT1;DGAT1;MOGAT2
prerank,histone deacetylase activity (GO:0004407),0.40848813561514646,0.9346740476110842,0.5452991452991452,0.9282963088600865,1.0,1/19,0.51%,HDAC9
prerank,Wnt-activated receptor activity (GO:0042813),0.4393226456526558,0.9344175663387791,0.5493482309124768,0.9253029750087067,1.0,4/15,4.59%,FZD6;FZD4;LRP5;TSPAN12
prerank,sterol binding (GO:0032934),-0.2837974967672143,-0.9343141415238165,0.5867158671586716,0.8947044136993675,1.0,17/56,15.62%,SIDT1;GRAMD1B;GRAMD1C;INSIG2;APOD;RORA;OSBPL8;OSBPL5;ANXA6;SOAT1;OSBPL3;CD81;OSBPL6;VDAC1;INSIG1;SCP2;SYP
prerank,organic anion transmembrane transporter activity (GO:0008514),0.30877036433949934,0.933320517095226,0.5806845965770171,0.9242664292782531,1.0,9/134,4.92%,ABCC4;SLCO2B1;ABCG2;SLC39A8;SLCO2A1;SLC38A5;SLC3A2;SLC6A6;SLC35B3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.44490707521668316,0.9312058433859779,0.5452930728241563,0.9256307140428185,1.0,2/13,2.68%,SLC7A7;SLC38A5
prerank,adrenergic receptor binding (GO:0031690),-0.3707941480037771,-0.9310744561918742,0.5613207547169812,0.8972061767022971,1.0,4/16,8.32%,MAGI2;DLG4;GNAS;ADRA2A
prerank,neuropeptide binding (GO:0042923),0.4147362559122036,0.9303126067635428,0.5203539823008849,0.924181463980881,1.0,4/18,18.65%,MCHR1;NMUR2;MC4R;OPRL1
prerank,mechanosensitive ion channel activity (GO:0008381),0.4568132161907979,0.9293154048416369,0.5562913907284768,0.9229388968385899,1.0,1/12,1.03%,PIEZO1
prerank,gated channel activity (GO:0022836),0.4452084414013747,0.9286030425351087,0.5963455149501661,0.9210083318675273,1.0,1/14,1.03%,PIEZO1
prerank,androgen receptor binding (GO:0050681),0.39634700254519845,0.9282922641410412,0.5629984051036683,0.9182630599292777,1.0,5/25,8.10%,FOXP1;KDM3A;PKN1;TRIM68;KDM4C
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.39930640423013986,0.9281173294407777,0.5478806907378336,0.9151885546259518,1.0,4/21,2.87%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,protein kinase inhibitor activity (GO:0004860),-0.29356496469588167,-0.9264401849137613,0.6006389776357828,0.9029796903768569,1.0,12/42,15.70%,SPRED1;PARVA;TAOK3;CIT;DNAJC3;CAMK2N1;SPRED2;CDKN1A;CEP43;SMCR8;SNCA;CDKN1C
prerank,RNA cap binding (GO:0000339),-0.37629463644657873,-0.9253426612598381,0.5630630630630631,0.9002559231529793,1.0,3/16,10.90%,CYFIP2;EIF4A1;EIF4E3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.44748759865544907,0.9248083184744436,0.5692007797270955,0.9157491763660408,1.0,5/11,20.73%,GRPEL1;BAG4;BAG1;SIL1;BAG2
prerank,adenyl nucleotide binding (GO:0030554),0.44748759865544907,0.9248083184744436,0.5692007797270955,0.9157491763660408,1.0,5/11,20.73%,GRPEL1;BAG4;BAG1;SIL1;BAG2
prerank,receptor tyrosine kinase binding (GO:0030971),0.34438359682692216,0.9246450732193945,0.5994277539341917,0.9127586218084343,1.0,12/56,15.29%,PTPN14;PITPNM2;DOCK4;NCK1;SH2B2;GRB14;PTPN1;GAS6;CBL;RACK1;LRP4;ALKAL2
prerank,ankyrin binding (GO:0030506),-0.35568311610420894,-0.9229009242373454,0.5631067961165048,0.9003793883393191,1.0,5/19,8.78%,CACNA1D;SLC8A1;CDH1;FLNC;NRCAM
prerank,nuclear export signal receptor activity (GO:0005049),0.45227545457514434,0.9211656656920627,0.5557553956834532,0.9171594422796423,1.0,5/11,24.27%,XPO1;NUP214;CSE1L;EIF4ENIF1;NUP42
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3214533280800151,0.9195158514242278,0.5686546463245492,0.9173454002198961,1.0,11/75,13.15%,ABCC4;RDH16;HADHA;CBR1;GLYR1;SPR;LDHD;ADH1A;SORD;HADH;IMPDH1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3882842417254884,0.9192559430081388,0.5599369085173501,0.9145310798330246,1.0,3/26,4.53%,PPP1R2;PPP1R9B;LMTK2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3895462685076501,0.9187853966925075,0.5620094191522763,0.9122848548778141,1.0,4/23,2.87%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,exoribonuclease activity (GO:0004532),0.4544528387889497,0.9181599050025597,0.5469924812030075,0.9101994857982575,1.0,3/12,13.14%,CNOT6;EXOSC1;CNOT7
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.312113730548497,-0.9178349918283681,0.603399433427762,0.9075471743523778,1.0,9/32,16.60%,KDM7A;TET1;KDM2A;EGLN3;P4HTM;KDM8;BBOX1;FTO;PHYHD1
prerank,aminopeptidase activity (GO:0004177),-0.3217643560914699,-0.9177816344603128,0.5797872340425532,0.9023385677663083,1.0,6/26,16.68%,MMP14;MMP16;NPEPPS;ENPEP;KDM8;BLMH
prerank,magnesium ion binding (GO:0000287),0.2971205192893727,0.916906298323768,0.6118090452261307,0.90954398949704,1.0,37/135,20.94%,SNRK;ERN1;PDE2A;SIK1;STK3;STK4;CDC42BPB;MAST2;SIK3;TSSK6;STK26;NEK6;DUT;NUDT16;HPRT1;FAN1;NT5C3A;ABL2;SIK2;STK38;MTPAP;MAP3K20;PDXP;ENDOV;IRAK3;RHEB;YDJC;NIM1K;PLSCR1;PRKACB;DHX36;NLK;PDCD6;MSH2;PGM1;MAP2K7;PLK1
prerank,omega peptidase activity (GO:0008242),0.3149357535603389,0.9160773508979347,0.6061776061776062,0.9081758448677737,1.0,18/89,19.17%,USP53;USP3;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4;APEH;GGH;USP12;OTULIN;YOD1;USP8;DESI2;USP7;USP25;USP21
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.38097350629568283,-0.9157424783819375,0.5610328638497653,0.9019481297643235,1.0,2/15,7.48%,P2RX4;P2RY14
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3439723205300301,0.914301667548244,0.6005788712011577,0.9087403567422419,1.0,7/46,8.79%,LFNG;MGAT4A;MFNG;B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,C-C chemokine binding (GO:0019957),0.39913028130386397,0.9134179801708987,0.5916666666666667,0.9071890343805686,1.0,6/22,20.77%,ACKR1;CX3CR1;CXCR4;ZFP36;CCR1;CXCR6
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3732965515559573,-0.9101117645531417,0.5977272727272728,0.9050126599033863,1.0,4/16,12.91%,ATP6V0A4;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3732965515559573,-0.9101117645531417,0.5977272727272728,0.9050126599033863,1.0,4/16,12.91%,ATP6V0A4;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,phosphatase binding (GO:0019902),0.3041378177340215,0.9091614614918402,0.6305483028720626,0.9132673679308787,1.0,20/105,10.57%,CTSC;IQGAP1;STAT3;PXN;FLT4;JAK3;CEACAM1;MAST2;SKAP1;CDKN1B;LCK;JAK1;PTK2;SNX3;SHOC2;ANAPC7;FBXL2;ANK1;AP3B1;SH3YL1
prerank,peptidase activator activity (GO:0016504),0.38896061801906073,0.9074814321646324,0.5846153846153846,0.9134753641077015,1.0,6/22,16.97%,CAV1;MAL;APH1A;PSME1;VSIR;CASP8AP2
prerank,cyclic nucleotide binding (GO:0030551),0.401001609641165,0.9067031912528493,0.5827702702702703,0.9118462415899207,1.0,4/21,6.12%,PDE2A;PDE4D;CNGB1;RAPGEF2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4339870532673177,0.9063978707438056,0.5842696629213483,0.9092455919830048,1.0,5/12,18.64%,KDM3A;JMJD1C;KDM4C;KDM4A;KDM1A
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4224487619972209,0.9049565015326747,0.5891608391608392,0.9088848018445305,1.0,2/14,7.06%,KCNQ1;KCNE2
prerank,insulin-like growth factor I binding (GO:0031994),0.43168631710222144,0.9047420292717401,0.563922942206655,0.9061280237302431,1.0,2/13,1.57%,ITGA6;INSR
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4126939432128458,-0.9039909323659876,0.6061946902654868,0.9137987341181595,1.0,4/10,8.10%,DPP4;FAP;NAALAD2;DPP6
prerank,DNA secondary structure binding (GO:0000217),0.36390918482132023,0.9014233455094004,0.581039755351682,0.9099182282396203,1.0,5/31,10.76%,MEF2C;LIN54;RAD51D;RAD18;XRCC2
prerank,cation:chloride symporter activity (GO:0015377),0.4567141816760685,0.8994101076061085,0.6003787878787878,0.9108467023937478,1.0,2/10,7.83%,SLC12A7;SLC12A9
prerank,transforming growth factor beta binding (GO:0050431),0.3842030138802846,0.8990366365177853,0.5972696245733788,0.9083291726347639,1.0,3/23,2.12%,ENG;ACVRL1;NRROS
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.3932173768784284,-0.8962164514282894,0.5923423423423423,0.9264458443064364,1.0,2/11,14.85%,AKR1B1;RDH13
prerank,GABA receptor binding (GO:0050811),-0.3990331514271679,-0.8958547514384188,0.6072234762979684,0.9218045814347697,1.0,6/11,26.28%,ARFGEF2;TRAK1;SHISA7;PLCL2;GABARAP;JAKMIP1
prerank,ribosomal small subunit binding (GO:0043024),0.41300474496879686,0.893694003547605,0.5882352941176471,0.9162770515075962,1.0,6/17,17.60%,EIF1;UNG;PIM1;NPM1;MTIF3;PTCD3
prerank,endoribonuclease activity (GO:0004521),0.35211407111696436,0.8931560383795697,0.5924713584288053,0.9142823540372336,1.0,11/32,24.13%,ERN1;KHNYN;DICER1;INTS11;ZC3H12C;ENDOV;ENDOG;RIDA;LACTB2;SND1;SMG6
prerank,metallocarboxypeptidase activity (GO:0004181),-0.31604894102604697,-0.8913527051619599,0.6185819070904646,0.9268936978763891,1.0,10/26,24.80%,AEBP1;CPXM2;CPXM1;AGBL4;CPM;AGBL1;ACE2;AGBL2;PEPD;CPZ
prerank,serotonin receptor activity (GO:0099589),0.3891842071839658,0.8893766219848668,0.6237288135593221,0.9123847666139492,1.0,1/22,1.96%,HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3891842071839658,0.8893766219848668,0.6237288135593221,0.9123847666139492,1.0,1/22,1.96%,HTR2A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3891842071839658,0.8893766219848668,0.6237288135593221,0.9123847666139492,1.0,1/22,1.96%,HTR2A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3731185823978519,0.8856668522853515,0.6183574879227053,0.9167703882940027,1.0,4/26,4.80%,ABCG2;SLC16A9;SLC16A2;SLC6A6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.42896168736569373,0.885332212355151,0.5962962962962963,0.9143497729813501,1.0,2/10,8.38%,GDA;DCTD
prerank,ubiquitin-protein transferase activity (GO:0004842),0.26886630632219216,0.8851837782417437,0.7398720682302772,0.9115024333719872,1.0,58/346,14.50%,RNF125;SMURF1;RNF144B;RNF141;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;TRAF1;ZNRF3;UBA7;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;PELI1;XIAP;MYCBP2;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;TRIM47;UBE2G1;RNF167;NEDD4;TRIM25;RNF139;MALT1;UBR1;TRIM24;UBE2H;NEURL3;NEURL1B;RNF146;FBXW2;RNF4;SIAH1;UBE2D3;RC3H1;CBL;UBE3A;CUL1;RNF112;HECTD1;COP1;MYLIP;BIRC3;RNF25;ASB4;RNF215;FBXL3;UBE2K;TRAF6;TOPORS
prerank,bHLH transcription factor binding (GO:0043425),0.39152089911381927,0.8840970416105189,0.6094276094276094,0.9105275990298167,1.0,4/19,10.33%,LMO2;TCF12;TCF3;USF2
prerank,hexosaminidase activity (GO:0015929),-0.3891773554180415,-0.8827723496272154,0.6331096196868009,0.9411313721205686,1.0,6/12,31.98%,CEMIP;HEXA;HYAL1;NAGA;HYAL3;HEXD
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.3373385944913251,-0.8825933019211599,0.6580188679245284,0.9362757115321476,1.0,10/21,34.76%,FGF1;FGF2;FGF7;FGF10;NPTN;FGF18;KLB;FGF22;FGF9;FGF5
prerank,phosphatidic acid binding (GO:0070300),0.3894171044627823,0.8791402765059908,0.5881383855024712,0.9172911714583247,1.0,8/19,23.07%,PLTP;RAPGEF2;PITPNC1;RAPGEF6;PACSIN2;OPA1;UQCC3;MAPKAP1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.42900881473836033,0.8785576299724136,0.6123893805309735,0.9154262290415556,1.0,4/12,17.69%,H3-3A;POU2F1;RELA;STAT1
prerank,insulin-like growth factor binding (GO:0005520),0.4083725940041783,0.8768909075067045,0.6055363321799307,0.9156469750200558,1.0,2/15,1.57%,ITGA6;INSR
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.43099146972760094,0.8763334205171845,0.6163410301953819,0.9137140631213613,1.0,4/12,8.79%,B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,SH2 domain binding (GO:0042169),0.35708125568085725,0.8762337198262448,0.6285266457680251,0.9108859184548719,1.0,8/31,8.99%,AFAP1L2;SH2B2;CCDC88A;SKAP1;LCK;PTK2;TRPV4;CRK
prerank,phosphatase activity (GO:0016791),-0.2555544991647678,-0.8729947298528158,0.7307692307692307,0.9524873380105031,1.0,15/73,15.24%,ATP1A2;PLPP3;ALPL;PXYLP1;DUSP11;LPIN1;EPHX2;LHPP;DUSP10;PTPN22;SBF1;PPP1CB;PLPPR5;ACP6;APTX
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.30252757391503593,-0.8696234451414261,0.6693333333333333,0.9544681689293916,1.0,9/29,12.77%,SPRED1;YWHAG;PKIA;CIT;PRKAG2;PRKAR1B;SPRED2;PRKAR1A;CDKN1A
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3856407252170157,-0.8688074568811283,0.6160714285714286,0.9507976866772755,1.0,4/11,19.30%,HNRNPA2B1;RAD50;HNRNPA1;TERF2
prerank,chloride channel regulator activity (GO:0017081),0.40445040069051286,0.8680763658208043,0.6105072463768116,0.9237604650669499,1.0,5/14,11.53%,STX7;STX1A;SGK3;VAMP8;STX8
prerank,filamin binding (GO:0031005),-0.3864496595672202,-0.8675521588750779,0.634032634032634,0.9481228380813159,1.0,1/11,0.52%,DPYSL3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3877036747873778,0.8669769900756203,0.6288288288288288,0.9226631684747291,1.0,6/18,16.85%,TMOD3;PDLIM1;CNN3;STXBP6;PAK4;PDLIM5
prerank,metal ion binding (GO:0046872),0.25693723011813685,0.8657675752526217,0.8132214060860441,0.9219281474202025,1.0,58/477,11.67%,CSGALNACT1;MCTP1;TGM2;SNRK;LCP1;ERN1;PIR;PLA2G4A;IQGAP1;PDE2A;PPP3CA;PITPNM2;TPD52;SIK1;ESYT2;RASGRP3;STK3;SELP;CDH2;STK4;PADI4;CDC42BPB;ENPP2;SPARCL1;ASAH2;RET;MAST2;PAM;PPP3CB;CHP2;RAPGEF2;SIK3;PLA2G2D;FBP1;TSSK6;STK26;BNIP2;ITPR3;AGRN;CDH15;MICU2;PKD2;LPL;NEK6;IHH;DUT;NUDT16;CDH23;HPRT1;FAN1;CD320;NT5C3A;SYT15;ABL2;SIK2;STK38;GRIN1;CDHR5
prerank,sequence-specific mRNA binding (GO:1990825),-0.40244492461649767,-0.8644065209512903,0.6782608695652174,0.9499900955593689,1.0,5/10,28.90%,LARP6;SHFL;RBM24;SSB;DHX9
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3898509882050397,-0.8618881429365659,0.6233480176211453,0.9501614807342141,1.0,2/10,4.64%,ANO1;CLCN2
prerank,amyloid-beta binding (GO:0001540),0.3003062995342847,0.8603382139776872,0.6643550624133149,0.9291497605739883,1.0,13/79,11.71%,APBB2;INSR;FZD6;FZD4;BCHE;ATP1A3;CACNA1A;ITM2A;CLSTN1;EPHA4;ITGA2;GRIN1;PICALM
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.36677069749141594,-0.8565337851597958,0.6650366748166259,0.955942537252896,1.0,4/13,16.77%,AGPAT4;LCLAT1;LPCAT1;AGPAT3
prerank,water transmembrane transporter activity (GO:0005372),-0.37731080608900835,-0.8546995877816593,0.6349892008639308,0.9545420797604888,1.0,1/11,1.60%,PDPN
prerank,methylation-dependent protein binding (GO:0140034),0.3111252235136584,0.8539642387512165,0.6726768377253814,0.9383664918773724,1.0,16/57,19.77%,KMT2E;SPIN1;MTF2;CHD1;CDYL;TRIM24;GLYR1;ZMYND11;FMR1;ATRX;KDM4A;CXXC1;PHF19;ZCWPW2;ING3;RBBP5
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3444926155927748,0.8531028498193327,0.6471518987341772,0.9369811787288758,1.0,8/32,15.20%,SLC38A5;SLC3A2;SLC6A6;SLC43A2;SLC38A1;SLC25A38;SLC36A4;SLC7A5
prerank,metal ion:proton antiporter activity (GO:0051139),-0.36863140819802453,-0.8526865631228276,0.6629464285714286,0.9538322951474474,1.0,7/13,29.74%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC11A1;SLC9A4;SLC9A2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3638150502507147,0.8500904709275552,0.648881239242685,0.9366379652674102,1.0,3/21,9.31%,CDK6;CCNK;CDK2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3638150502507147,0.8500904709275552,0.648881239242685,0.9366379652674102,1.0,3/21,9.31%,CDK6;CCNK;CDK2
prerank,growth factor activity (GO:0008083),-0.24935950527255824,-0.8499584103388369,0.8027681660899654,0.9545280306898093,1.0,19/74,19.90%,PTN;FGF1;FGF2;IGF2;NGF;JAG1;NRG3;OSGIN2;VEGFB;VEGFA;INHBA;FGF7;HBEGF;MDK;PDGFA;FGF10;ANGPTL3;CLCF1;NTF3
prerank,symporter activity (GO:0015293),-0.38483024646455133,-0.8473493549311174,0.6553911205073996,0.9545157692989054,1.0,3/10,14.19%,SLC5A5;SLC5A6;MFSD2A
prerank,telomeric DNA binding (GO:0042162),0.3412427131327398,0.8457518220145926,0.6791862284820032,0.9420764294096926,1.0,12/32,24.13%,HMBOX1;RPA1;HNRNPD;SMG7;ACD;UPF2;TERF1;KDM1A;PURA;TEN1;TELO2;SMG6
prerank,sodium:proton antiporter activity (GO:0015385),-0.37476430439384245,-0.8442725615401341,0.6725274725274726,0.9558177280752228,1.0,6/11,29.74%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC9A4;SLC9A2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3614296608885039,0.8396211136827786,0.6716171617161716,0.9504416431233218,1.0,4/22,9.43%,RNF169;MINDY2;ZRANB1;IKBKG
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3732018221004512,-0.838882473913668,0.6767895878524945,0.961710400359945,1.0,2/12,10.90%,CYFIP2;EIF4E3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.42427768673165883,0.8387614696444171,0.650390625,0.9490017885682058,1.0,2/10,9.54%,CD200;IZUMO1
prerank,mannosyltransferase activity (GO:0000030),0.3745582734736437,0.8365077330666627,0.6436974789915967,0.950251220488167,1.0,1/21,0.82%,TMTC2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3419307028626882,0.8363850352138575,0.6672025723472669,0.9474616523234743,1.0,12/28,22.93%,MAP3K9;RPS6KA1;AURKA;AURKC;MAP2K3;MAPKAPK3;PRKCG;MAP2K5;MAP2K4;MAP2K7;MAP2K6;MAPK14
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3605443718983235,-0.8347220627078922,0.6950354609929078,0.9651672712263295,1.0,2/12,12.14%,AOX1;FDX1
prerank,lysine-acetylated histone binding (GO:0070577),-0.313442564006563,-0.8343193040848954,0.6966580976863753,0.9560507750756687,1.0,9/20,16.76%,PSME4;TAF1;SMARCA4;THAP7;BRD9;ZMYND8;BAZ2A;BRDT;CARM1
prerank,acetylation-dependent protein binding (GO:0140033),-0.313442564006563,-0.8343193040848954,0.6966580976863753,0.9560507750756687,1.0,9/20,16.76%,PSME4;TAF1;SMARCA4;THAP7;BRD9;ZMYND8;BAZ2A;BRDT;CARM1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.36453182130567063,0.833867031422468,0.6639344262295082,0.9492268462702367,1.0,1/20,0.92%,SLC39A8
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.3874489902994491,0.8325521429234616,0.6593591905564924,0.9485298812465606,1.0,2/15,6.70%,SLC39A8;SLC26A1
prerank,nuclease activity (GO:0004518),0.30580885041183803,0.8315236217339438,0.6964809384164223,0.9474030020634951,1.0,7/52,8.78%,SAMHD1;ISG20;N4BP1;RNASE1;RNASEH2A;ANG;RNASE4
prerank,histone methyltransferase binding (GO:1990226),0.40008977912679256,0.8295802439787487,0.6654205607476635,0.9478778880271839,1.0,6/11,22.76%,LCORL;HSP90AB1;CTNNB1;LCOR;PRDM4;PHF1
prerank,tau protein binding (GO:0048156),-0.2677197632231527,-0.8283324217608097,0.7841269841269841,0.9630240165051916,1.0,7/40,9.84%,ROCK2;MAP2;BRSK1;HSP90AA1;S100B;BIN1;APOE
prerank,disordered domain specific binding (GO:0097718),0.3543678815255664,0.8272788418621178,0.6760330578512397,0.9488310678257582,1.0,8/23,22.19%,FYN;TEAD2;RB1;HSP90AB1;CALM1;NUMA1;SMAD2;FN1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.33762472063580473,0.8243844560912493,0.6987381703470031,0.9511402155845856,1.0,2/30,3.36%,SLC39A8;SLC31A1
prerank,carboxylic acid binding (GO:0031406),0.3282800950023106,0.8212466349386908,0.7012578616352201,0.9537158131513078,1.0,3/38,8.53%,NOS3;PADI4;UBR1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24201239224187995,-0.8203834984201489,0.8333333333333334,0.973340263744955,1.0,16/74,16.55%,NADK2;PI4KA;GK;FAM20C;FAM20A;GALK2;PAPSS2;DGKD;DGKI;HK2;DCAKD;SPHK1;PIK3CD;MVK;GALK1;DGKQ
prerank,3'-5' exonuclease activity (GO:0008408),0.31082376510931686,0.8195078363902217,0.717037037037037,0.9538053728489478,1.0,13/45,22.17%,CNOT6;CNOT6L;ISG20;ANGEL2;REXO2;CNOT7;TRIR;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,chloride channel activity (GO:0005254),-0.2512795483027005,-0.8175400460387611,0.8,0.9737461231095706,1.0,13/59,15.49%,SLC26A7;GLRB;ANO1;CLCN2;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRB3;GABRG3;FXYD1;CLCN7
prerank,cytochrome-c oxidase activity (GO:0004129),-0.34106117401299907,-0.8173675601747153,0.7555555555555555,0.9691498440856947,1.0,12/15,53.52%,COX6B1;NDUFA4L2;COX4I2;COX7A1;NDUFA4;COX6A2;COX10;COX5B;COX15;COX8A;CYB5A;COX7A2L
prerank,ribosomal large subunit binding (GO:0043023),0.4038687834356791,0.8137933727021119,0.6763005780346821,0.9606745947585251,1.0,4/11,14.04%,RBM3;EIF6;MRRF;NPM1
prerank,CXCR chemokine receptor binding (GO:0045236),-0.3584181215485117,-0.81323454025395,0.6965065502183406,0.9719550116725174,1.0,3/11,13.60%,CXCL12;ITCH;YARS1
prerank,DNA polymerase binding (GO:0070182),-0.312994641165768,-0.811732759508963,0.7439613526570048,0.9699407492651975,1.0,4/18,12.56%,HSP90AA1;RTEL1;SMARCA4;FANCI
prerank,cardiolipin binding (GO:1901612),-0.3711056027863373,-0.8110543063371102,0.7105831533477321,0.9662467099366239,1.0,1/10,4.03%,GSDME
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3994249542331813,0.808823052928728,0.6743772241992882,0.9633481660007395,1.0,3/10,14.85%,DUSP16;DUSP7;DUSP2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3994249542331813,0.808823052928728,0.6743772241992882,0.9633481660007395,1.0,3/10,14.85%,DUSP16;DUSP7;DUSP2
prerank,sodium channel regulator activity (GO:0017080),0.3218337258922444,0.806154318585076,0.7119476268412439,0.964844359914928,1.0,5/37,8.62%,NEDD4L;FXYD6;ATP2B4;NEDD4;SGK3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3213801192403066,0.7999557042690466,0.7368421052631579,0.9725291445613425,1.0,15/34,26.18%,UBE2G1;UBE2H;UBE2D3;UBE2K;UBE2I;CDC34;UBE2Q1;UBE2L3;UBE2F;UBE2J2;UBE2D1;UBE2R2;UBE2E1;AKTIP;UBE2N
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.34630080244683265,-0.7977929543552335,0.7260579064587973,0.9842672446645314,1.0,6/12,29.74%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC9A4;SLC9A2
prerank,ligand-gated calcium channel activity (GO:0099604),-0.30672529478743127,-0.7972447961220556,0.7375886524822695,0.9803697228078673,1.0,4/19,13.75%,P2RX4;RYR2;GRIN2A;GRIN2D
prerank,MAP kinase kinase activity (GO:0004708),0.3673076255123725,0.7961725533874314,0.6994727592267135,0.9760419226816579,1.0,8/15,22.93%,MAP3K9;MAP2K3;MAPKAPK3;MAP2K5;MAP2K4;MAP2K7;MAP2K6;MAPK14
prerank,ATPase regulator activity (GO:0060590),0.31084740089311874,0.7938517443724147,0.7445141065830722,0.9767815153946168,1.0,11/38,20.73%,FNIP2;DNAJA1;ATP1B3;GRPEL1;BAG4;BAG1;SIL1;DNAJB1;DNAJC10;DNAJB6;BAG2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.3930718307078924,0.792001535581043,0.6938405797101449,0.9768532567609216,1.0,3/10,14.68%,CDKN1B;INCA1;KAT2B
prerank,miRNA binding (GO:0035198),-0.27481356422633757,-0.7919814638969971,0.7954545454545454,0.9847655996289625,1.0,10/30,21.32%,HNRNPA2B1;AGO3;RBM4;ZC3H7B;HNRNPA1;DDX21;TUT4;ZNF346;SOX2;MATR3
prerank,methyl-CpG binding (GO:0008327),-0.292577902853797,-0.7919574749571281,0.7690217391304348,0.9800013123842419,1.0,4/22,12.33%,TET1;CXXC4;ZBTB38;CXXC5
prerank,chloride channel inhibitor activity (GO:0019869),0.3986591899669506,0.791480207141701,0.714828897338403,0.9747458880308086,1.0,4/10,11.53%,STX7;STX1A;VAMP8;STX8
prerank,NAD+ binding (GO:0070403),-0.33977398637306133,-0.7886033957193287,0.726027397260274,0.9809557572469781,1.0,2/12,4.18%,CRYL1;SIRT2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.35985404792019027,0.7884648842864305,0.70298769771529,0.9769089194868609,1.0,5/14,19.56%,RPP30;RPP25;TSEN34;TSEN2;PRORP
prerank,P-type ion transporter activity (GO:0015662),0.3837047329312234,0.7882372594796869,0.7023172905525846,0.9743261409350928,1.0,3/12,10.25%,ATP2B4;ATP2C1;ATP7B
prerank,pentosyltransferase activity (GO:0016763),-0.26518918229038824,-0.7877299816274781,0.8011204481792717,0.977686708330826,1.0,8/36,17.31%,LARGE1;SIRT2;PARP3;PARP11;LACC1;QPRT;PARP8;ART3
prerank,histone demethylase activity (GO:0032452),0.32630586995193844,0.7872972481418142,0.7348242811501597,0.9729510694336004,1.0,10/27,22.77%,KDM3A;KDM6A;JMJD1C;KDM4C;JARID2;KDM5C;KDM4A;KDM1A;JMJD6;PHF2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3459731435764312,-0.7861153661028151,0.7569892473118279,0.9755668475809838,1.0,5/12,18.15%,SLC25A42;SLC19A1;SLC25A25;SLC25A23;SLC17A9
prerank,carboxypeptidase activity (GO:0004180),-0.26352353083333363,-0.7842067090210536,0.7867036011080333,0.973941254647647,1.0,11/35,19.06%,AEBP1;NAALAD2;CPXM2;CPXM1;AGBL4;SCPEP1;CTSZ;BLMH;CPM;AGBL1;ACE2
prerank,MHC class I protein binding (GO:0042288),0.37718423130773704,0.7836839772745909,0.7140350877192982,0.9758334812550525,1.0,5/13,28.93%,TAP2;TAP1;TAPBP;ATP5F1B;ABCB9
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.349556902279054,-0.7827510576395401,0.7347368421052631,0.9717101994056413,1.0,5/11,18.15%,SLC25A42;SLC19A1;SLC25A25;SLC25A23;SLC17A9
prerank,myosin V binding (GO:0031489),0.3570067969583608,0.7818014978875616,0.7367491166077739,0.9760718625863243,1.0,5/15,22.84%,RAB11A;RAB11B;RAB6A;RAB25;RAB3A
prerank,peptide hormone receptor binding (GO:0051428),-0.34930361843311164,-0.7816857622377437,0.7483870967741936,0.9688774996161906,1.0,8/11,50.82%,CCK;PSMC5;ADCYAP1;PTHLH;VIP;UCN2;GPHB5;GHRH
prerank,histone acetyltransferase activity (GO:0004402),0.314618368100372,0.7799902272679222,0.7535101404056163,0.976029574722591,1.0,8/30,16.90%,EPC1;ARRB1;KAT6B;HAT1;SRCAP;KAT2B;KAT6A;BAZ1A
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3692110667460713,0.7799005645903714,0.6921768707482994,0.9733233541509735,1.0,4/14,25.59%,AK4;CMPK1;DTYMK;AK1
prerank,phosphatidate phosphatase activity (GO:0008195),0.36484077586100305,0.7791729884334145,0.7338129496402878,0.9716383145141649,1.0,2/13,5.65%,PLPP1;LPIN3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.29837158434074307,-0.7781564636918483,0.8014705882352942,0.9699813735619013,1.0,5/22,12.91%,ATP6V0A4;ATP2A2;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,mRNA binding (GO:0003729),0.24167789100862558,0.7777327512157096,0.9063545150501672,0.9710412281069659,1.0,49/249,16.02%,NANOS3;NOVA2;RBPMS;ADARB1;IGF2BP3;RPS14;RBM20;PTBP3;NANOS2;N4BP1;EDC3;CNBP;RPS7;HNRNPA0;HNRNPK;RBM14;SRBD1;MARF1;RBM25;THOC2;KHNYN;YBX3;NUDT16;G3BP1;PUM1;HNRNPLL;SERBP1;ANGEL2;RPL13A;YTHDC1;RC3H1;RBM15;RNPS1;MRPL13;PUM2;NUP98;HNRNPC;ZFP36;FMR1;SF3B6;QKI;ZC3H12C;LARP4B;NSRP1;RPS13;LSM14A;AQR;G3BP2;LUC7L2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3177843694974464,-0.7769248311259991,0.7614457831325301,0.9673494888015141,1.0,4/15,16.77%,AGPAT4;LCLAT1;LPCAT1;AGPAT3
prerank,protein kinase activator activity (GO:0030295),0.2794597140419629,0.7761423199143107,0.8093278463648834,0.9706800481459749,1.0,9/60,10.66%,IQGAP1;AFAP1L2;STK3;PAK2;STK4;RPLP1;RPTOR;RICTOR;GAS6
prerank,receptor antagonist activity (GO:0048019),-0.3089104502751365,-0.7747953219478642,0.7615740740740741,0.9660931358706103,1.0,2/17,11.08%,DKK3;DKK2
prerank,R-SMAD binding (GO:0070412),-0.29469353142849003,-0.7744413749388138,0.8141361256544503,0.962126256180315,1.0,4/18,9.53%,DDX5;SMAD6;SMAD3;RGCC
prerank,MAP kinase phosphatase activity (GO:0033549),0.36970839351515794,0.773110303736779,0.7102473498233216,0.9726325519517924,1.0,3/12,14.85%,DUSP16;DUSP7;DUSP2
prerank,nucleosomal DNA binding (GO:0031492),-0.29549448859102123,-0.7719633118194796,0.7876543209876543,0.9611303487366811,1.0,8/21,23.60%,CHD4;SMARCA4;SMARCB1;MTA2;ACTL6A;RBBP4;SMARCD2;RCC1
prerank,endopeptidase activator activity (GO:0061133),0.3887353527301065,0.7704150262682624,0.7204502814258912,0.9739700506902846,1.0,4/10,23.19%,APH1A;PSME1;VSIR;ADRM1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.35070405337339894,-0.7703496506982688,0.7744034707158352,0.9589371345382327,1.0,3/10,9.20%,ECHDC1;ECHDC3;ECHDC2
prerank,signal sequence binding (GO:0005048),0.30796418678584103,0.7700311133506834,0.7671451355661882,0.9717805318112379,1.0,4/35,4.99%,NFKBIA;BABAM2;CAT;AP2B1
prerank,methylated histone binding (GO:0035064),0.2758925894675251,0.7686459527716281,0.8170731707317073,0.9709791645379531,1.0,19/62,22.77%,KMT2E;SPIN1;MTF2;CHD1;CDYL;TRIM24;GLYR1;ZMYND11;FMR1;ATRX;KDM4A;CXXC1;PHF19;ZCWPW2;ING3;RBBP5;TAF7;PHF1;PHF2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3406167498997911,-0.7674317825554101,0.7724137931034483,0.9588970052476613,1.0,3/11,14.01%,SLC5A3;SLC2A10;SLC5A11
prerank,WW domain binding (GO:0050699),0.32037549510333874,0.762434530328818,0.7727272727272727,0.977816033803309,1.0,7/26,20.23%,RAPGEF2;DAZAP2;CDC25C;PMEPA1;NDFIP2;LITAF;TCEAL9
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.37407984273796197,0.7622274780066094,0.7014925373134329,0.9753374085800056,1.0,2/10,4.20%,PRKAR2B;PKIG
prerank,RNA stem-loop binding (GO:0035613),-0.3336919223449186,-0.7613086545637068,0.8084632516703786,0.9633529387161538,1.0,3/12,15.36%,CPEB3;LARP6;RC3H2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.3149315072764741,-0.7571990357233255,0.7867298578199052,0.9647266563273593,1.0,1/15,2.77%,CCR9
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3293368275000003,0.7552662147625956,0.7993366500829188,0.982999459707293,1.0,4/24,14.73%,ITPKB;AK4;CMPK1;PMVK
prerank,epidermal growth factor receptor binding (GO:0005154),0.31477501660664514,0.7523380191273911,0.7588996763754046,0.984593837147573,1.0,9/25,19.31%,HIP1;CCDC88A;TGFA;SNX4;SNX1;GRB2;PLSCR1;LINGO1;BTC
prerank,microtubule plus-end binding (GO:0051010),-0.29678592499990764,-0.7522634833098435,0.8164251207729468,0.9671033553461507,1.0,3/20,6.34%,CLIP4;CLIP3;STIM1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3013523620903985,0.7520427564261337,0.8040435458786936,0.9822133303027196,1.0,5/32,11.36%,KCNQ1;KCNB1;KCNE2;KCNG4;KCNA4
prerank,transferrin receptor binding (GO:1990459),-0.3388034728500109,-0.7501466928221642,0.7773109243697479,0.9655564386681131,1.0,3/10,11.16%,RGMA;CHUK;CD81
prerank,muscle alpha-actinin binding (GO:0051371),-0.309246130568375,-0.7491515520561521,0.8027210884353742,0.9626272588806539,1.0,5/15,16.90%,PALLD;PDLIM7;PDLIM4;LDB3;PDLIM2
prerank,motor activity (GO:0003774),0.2754338836348176,0.7469708505834033,0.8451882845188284,0.9869312012591823,1.0,12/60,12.55%,MYH9;STARD9;KIF26A;DNAH3;KIF22;MYO1E;DYNLRB1;KIF23;KIF19;DNAH17;MYL6B;KIF16B
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3276429872573365,0.7466791324298144,0.7736757624398074,0.9845209697738541,1.0,4/20,13.77%,TJP2;AK4;MAGI3;CMPK1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.3585285415630105,0.7451948388304839,0.7617391304347826,0.9838476711188923,1.0,2/12,12.21%,OPN4;OPN5
prerank,potassium:proton antiporter activity (GO:0015386),-0.34101120664309525,-0.744788041355639,0.7765486725663717,0.9641782431834995,1.0,5/10,29.74%,SLC9A9;SLC9A1;SLC9A8;SLC9A4;SLC9A2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.33957447736605,0.7427913430223264,0.7575250836120402,0.9842892880626962,1.0,9/17,35.24%,AK4;CMPK1;DTYMK;AK1;AK3;NME1;AK8;CLP1;NME6
prerank,mRNA methyltransferase activity (GO:0008174),0.36124969828908743,0.7422613992726613,0.7710622710622711,0.9822584464445584,1.0,6/12,27.22%,RNMT;METTL14;TRMT10C;TRMT61B;METTL16;NSUN2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3343698438497489,-0.7401909944360916,0.8085585585585585,0.9660478947759479,1.0,2/11,10.03%,NUDT4;NUDT7
prerank,endonuclease activity (GO:0004519),0.27419016227409737,0.7381564173827875,0.8300455235204856,0.9853543517972442,1.0,7/49,14.46%,ERN1;ANG;KHNYN;DICER1;INTS11;ERCC4;ZC3H12C
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.24404938767617607,-0.736204784577855,0.8823529411764706,0.9667291428206531,1.0,13/34,28.16%,KMT5A;EHMT2;SETDB1;DOT1L;SETD4;VCPKMT;MEN1;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;SETD7;EEF1AKMT3
prerank,tubulin binding (GO:0015631),0.224922294389831,0.735430539135594,0.9616228070175439,0.9865485034962628,1.0,37/295,14.39%,DNM3;MTUS1;DIXDC1;RAB11A;ARHGEF2;REEP1;DST;STARD9;FYN;KIF26A;DIP2B;RAB11FIP5;MAST2;TTLL7;CCDC88A;MID2;TRPV4;KIF22;PHF6;ARHGEF7;TBCA;RAD51D;CEP57;PRUNE1;ARL8B;KIF23;KIF19;EML6;GABARAPL1;KIF16B;FMR1;PEX14;NDEL1;TTLL5;APC;S100A9;MID1
prerank,CoA hydrolase activity (GO:0016289),-0.30383805728982,-0.7307294986268223,0.80440097799511,0.9694216142586506,1.0,8/16,38.22%,ACOT11;NUDT7;ACOT9;ACOT8;ACOT1;ACOT7;HIBCH;ACOT12
prerank,snRNA binding (GO:0017069),-0.23677933252964486,-0.7287170306877144,0.9072463768115943,0.9677057303539084,1.0,11/42,25.23%,SNRNP70;DDX39B;CCNT2;CDK9;HNRNPU;DDX21;RNPC3;SNRPA1;RBM41;HEXIM2;SNRNP35
prerank,voltage-gated anion channel activity (GO:0008308),-0.2965530058300996,-0.7271138280713899,0.8220140515222483,0.9652764983358332,1.0,5/15,20.96%,ANO1;CLCN2;VDAC1;CLCN1;VDAC2
prerank,translation elongation factor activity (GO:0003746),0.3343189159432625,0.7262491445373591,0.792910447761194,0.9959309032334012,1.0,5/14,25.98%,EEFSEC;EEF2;EIF5A;EIF5AL1;GFM1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3149888062173907,-0.7249651860081875,0.8474178403755869,0.963641901892467,1.0,4/13,29.29%,TARBP1;THUMPD3;METTL1;TRMT10B
prerank,GTPase inhibitor activity (GO:0005095),0.34157876612132915,0.7247574808600147,0.7757352941176471,0.995179173544066,1.0,1/13,2.10%,IQGAP1
prerank,leucine zipper domain binding (GO:0043522),-0.325333410649167,-0.7225186470741736,0.8004484304932735,0.9624896820673068,1.0,1/10,0.74%,PAWR
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.29105009682220884,0.7177557375237122,0.8214285714285714,1.0,1.0,13/31,26.18%,UBE2G1;UBE2H;UBE2D3;UBE2K;CDC34;UBE2Q1;UBE2L3;UBE2J2;UBE2D1;UBE2R2;UBE2E1;AKTIP;UBE2N
prerank,monocarboxylic acid binding (GO:0033293),0.3179743604448463,0.7125222663747345,0.8330373001776199,1.0,1.0,2/18,6.57%,CYP26A1;CYP26C1
prerank,methyltransferase activity (GO:0008168),-0.22353907529089215,-0.706933907678042,0.9173789173789174,0.9760437787264711,1.0,23/46,38.54%,FTSJ3;METTL27;COQ5;LCMT1;NDUFAF7;ASMT;BUD23;EEF1AKMT1;NNMT;PRMT8;RRP8;BCDIN3D;EEF1AKMT3;AS3MT;NTMT1;PRMT7;MEPCE;COMTD1;EEF1AKMT4;AMT;PRMT1;EEF1AKMT2;METTL4
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3116138255174847,0.7052669364013738,0.8215488215488216,1.0,1.0,6/19,17.12%,AFAP1L2;PAK2;GREM1;GAS6;ALKAL2;ABI1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.2801185769502106,0.6976659441827329,0.875968992248062,1.0,1.0,3/31,8.09%,SLC12A7;SLC12A9;PKD2
prerank,tRNA methyltransferase activity (GO:0008175),-0.28545271076128287,-0.6948587080319691,0.8503401360544217,0.9847483737634571,1.0,10/16,44.88%,TARBP1;THUMPD3;BCDIN3D;METTL2A;METTL2B;THUMPD2;TRMT13;TRMT9B;TRMT44;FTSJ1
prerank,cholesterol binding (GO:0015485),0.267229152977151,0.6945430979021876,0.8780141843971632,1.0,1.0,5/47,8.02%,CAV1;STARD5;PROM1;OSBPL10;SOAT2
prerank,exonuclease activity (GO:0004527),0.26650989382983326,0.6919716416095729,0.8781954887218045,1.0,1.0,9/46,15.02%,CNOT6;ISG20;ENPP2;FAN1;REXO2;EXOSC1;CNOT7;TRIR;XRN2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2759164652752254,0.6913829769757642,0.865814696485623,1.0,1.0,10/34,24.69%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2759164652752254,0.6913829769757642,0.865814696485623,1.0,1.0,10/34,24.69%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,phospholipase activity (GO:0004620),0.2488243587836141,0.6901832999054717,0.9158485273492286,1.0,1.0,7/67,9.99%,PLCB4;PLA2G4A;ENPP2;PLA2G2D;LPL;PLAAT3;GDPD1
prerank,nuclear localization sequence binding (GO:0008139),0.3066271677909383,0.6895795792473683,0.8578856152512998,1.0,1.0,5/18,21.53%,NFKBIA;NUP214;NUP153;KPNB1;KPNA4
prerank,microtubule binding (GO:0008017),0.21373065579497663,0.6821744509043866,0.9873853211009175,1.0,1.0,31/222,16.82%,DNM3;MTUS1;RAB11A;ARHGEF2;REEP1;DST;STARD9;KIF26A;MAST2;CCDC88A;MID2;TRPV4;CAMSAP2;KIF22;CEP57;KIF23;KIF19;EML6;KIF16B;FMR1;PEX14;NDEL1;APC;S100A9;MID1;CEP290;CHP1;TERF1;CEP295;FNTA;ABRAXAS2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2530780270161079,0.6814048663664243,0.8991596638655462,1.0,1.0,8/60,7.19%,PPP3CA;PPM1F;PPM1L;PPP3CB;MTMR6;PGAM5;PPM1D;LCK
prerank,regulatory RNA binding (GO:0061980),-0.22483546078724537,-0.6757122126492835,0.9206349206349206,0.9993312909195528,1.0,11/38,22.42%,HNRNPA2B1;AGO3;RBM4;ZC3H7B;HNRNPA1;DDX21;TUT4;ZNF346;SOX2;MATR3;PIWIL2
prerank,RNA polymerase II complex binding (GO:0000993),-0.2285113744751842,-0.6755515672643064,0.9365994236311239,0.9952508750956657,1.0,8/32,19.54%,RECQL5;CTR9;PAF1;ERCC5;WDR43;HNRNPU;UVSSA;ELP4
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3312936886292124,0.6755174967264082,0.8302238805970149,1.0,1.0,3/10,18.34%,NAA11;NAA16;NAA30
prerank,mannose binding (GO:0005537),0.3316112269841328,0.6750419553804132,0.8205574912891986,1.0,1.0,3/12,26.59%,ACR;CLN5;LMAN2L
prerank,death receptor binding (GO:0005123),0.3157352822078526,0.6731722553652552,0.8360071301247772,1.0,1.0,5/15,19.21%,DAB2IP;RIPK1;BID;CASP8AP2;MADD
prerank,3'-5' DNA helicase activity (GO:0043138),-0.26751631951341986,-0.6721466090531601,0.8731343283582089,0.9941990080332072,1.0,2/16,6.00%,NAV2;RECQL5
prerank,translation initiation factor activity (GO:0003743),0.2673657086365926,0.6713749870141207,0.8946564885496183,1.0,1.0,8/36,15.99%,EIF4E;EIF3H;EIF1;EIF2B5;EIF5B;EIF2B2;MTIF3;EIF5
prerank,phosphatidylinositol kinase activity (GO:0052742),0.3089935174519293,0.6705409788102379,0.8563829787234043,1.0,1.0,2/15,7.41%,PIK3C2A;PIK3CG
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.31013869900220126,-0.6668846698770189,0.8640552995391705,0.9948492799549811,1.0,7/10,40.35%,POLD1;EXO1;DCLRE1B;EXD2;FEN1;MGME1;TATDN1
prerank,death domain binding (GO:0070513),0.3273463154842002,0.6625785453436083,0.8460111317254174,1.0,1.0,5/11,16.24%,CRADD;BCL2L1;RIPK1;RACK1;IRGM
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2522890325520619,0.6586463542267951,0.900887573964497,1.0,1.0,8/42,17.36%,CCNK;CDKN1B;CCNYL1;CCNY;INCA1;KAT2B;CCNJ;CCNC
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.2890678816228188,-0.6573654864595238,0.8811188811188811,0.9989598221759195,1.0,4/11,27.59%,APEX2;NEIL3;NTHL1;NEIL1
prerank,snoRNA binding (GO:0030515),0.27313899749738374,0.6555988781557627,0.8966074313408724,1.0,1.0,8/30,18.90%,IMP3;ISG20;NUDT16;RRP9;UTP6;HEATR1;NOP14;NUDT1
prerank,aspartic-type peptidase activity (GO:0070001),0.32317861814445115,0.6504968199093287,0.8348457350272233,1.0,1.0,4/10,26.86%,PSEN1;DDI2;NAPSA;CTSE
prerank,ubiquitin binding (GO:0043130),0.22831941273826056,0.6441297480813563,0.9472954230235784,1.0,1.0,22/73,23.19%,MVB12B;FBXW7;N4BP1;NEDD4;IKBKG;VPS28;RAD23A;CXCR4;BUB3;ILRUN;UBXN1;DDI2;BIRC2;WDR48;GGA3;USP25;TSG101;VPS36;UBXN2A;FBXO7;UCHL3;ADRM1
prerank,RNA methyltransferase activity (GO:0008173),0.28906681351603836,0.6415259938319862,0.8834782608695653,1.0,1.0,3/19,13.10%,TGS1;FBLL1;HENMT1
prerank,neuropeptide receptor activity (GO:0008188),-0.22253442728433692,-0.6371094133178221,0.94750656167979,1.0,1.0,3/29,7.45%,SORCS2;SORCS1;SORCS3
prerank,channel activity (GO:0015267),0.23946527750487526,0.6342225199328929,0.93993993993994,1.0,1.0,6/41,14.87%,AQP11;TRPV6;TRPV4;MCUB;PANX1;CHRNB1
prerank,kinase inhibitor activity (GO:0019210),0.260633682361302,0.6337645667408413,0.937791601866252,1.0,1.0,11/33,19.79%,NCK1;CDKN1B;GMFG;WARS1;TRIB1;GSKIP;NPM1;MBIP;SH3BP5L;PRKRIP1;DUSP19
prerank,hormone activity (GO:0005179),-0.19191948874703438,-0.6315535882534199,0.984472049689441,1.0,1.0,1/54,0.34%,IGF1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2788401283402224,0.628286837478067,0.9038817005545287,1.0,1.0,2/18,13.32%,RDH16;SRD5A2
prerank,lipase activity (GO:0016298),0.24426345368509214,0.6282309268752303,0.9295154185022027,1.0,1.0,8/43,18.96%,ABHD2;LIPE;LPL;PNPLA2;PNPLA8;FAAH;LIPA;CEL
prerank,ribosome binding (GO:0043022),-0.2023858280829228,-0.6265016278791824,0.9814241486068112,1.0,1.0,8/46,16.54%,CPEB1;CPEB2;CPEB3;CPEB4;EIF3C;SHFL;SEC61A2;IGHMBP2
prerank,microtubule minus-end binding (GO:0051011),0.2958621194990695,0.6213334793552874,0.8794063079777366,1.0,1.0,7/13,29.49%,CAMSAP2;CEP290;NUMA1;TUBGCP2;CAMSAP1;HAUS4;TUBGCP3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.29673228784961647,0.6211103476787422,0.9029850746268657,1.0,1.0,3/12,18.17%,CBR1;CBR4;NQO2
prerank,N-acetyltransferase activity (GO:0008080),0.2704108411285148,0.6201919530646525,0.9119718309859155,1.0,1.0,3/19,14.68%,NAT2;SMARCE1;KAT2B
prerank,NADPH binding (GO:0070402),0.2929758058311826,0.6166186660815849,0.9003690036900369,1.0,1.0,1/13,3.41%,LBR
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2932771925970605,0.6126419388277095,0.8946395563770795,1.0,1.0,3/13,15.10%,DICER1;FAN1;ENDOV
prerank,exopeptidase activity (GO:0008238),0.23072605935757062,0.6100206942320006,0.9555873925501432,1.0,1.0,9/50,15.61%,PRCP;CPE;PM20D2;ERAP1;NUDT16;LAP3;GGH;ACE;ZMPSTE24
prerank,5'-nucleotidase activity (GO:0008253),0.2838058627638562,0.608193816836787,0.9078014184397163,1.0,1.0,2/13,10.88%,NT5C2;NT5C3A
prerank,microtubule motor activity (GO:0003777),0.2293639374661112,0.6069429635307716,0.9548762736535662,1.0,1.0,9/51,12.55%,STARD9;KIF26A;DNAH3;KIF22;DYNLRB1;KIF23;KIF19;DNAH17;KIF16B
prerank,Hsp70 protein binding (GO:0030544),0.24245524464008994,0.6058354829690368,0.9295558958652373,1.0,1.0,2/31,6.78%,ERN1;DNAJA1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.23692847862629593,0.6053016448627411,0.945054945054945,1.0,1.0,13/35,33.09%,PTRH1;NT5C3A;DTWD2;QRSL1;MTFMT;AARS2;LCMT2;TRMT12;TRIT1;GATC;ALKBH1;TYW3;PUS10
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.2181529771300571,-0.5994139053059737,0.9664948453608248,1.0,1.0,3/25,7.77%,SIRT2;PARP3;PARP11
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.2082358098487633,-0.5958336838446459,0.9722222222222222,1.0,1.0,11/27,31.44%,POLR2B;POLR3H;MED20;POLRMT;POLR2I;TERT;MED21;POLR3K;POLR2D;CRCP;POLR2G
prerank,CCR chemokine receptor binding (GO:0048020),-0.20819426293941276,-0.5949628188179998,0.970108695652174,1.0,1.0,17/28,47.43%,NES;CCL19;CCR2;CCL2;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.25493755844263805,0.5922839684034036,0.9282136894824707,1.0,1.0,4/22,11.71%,MESD;DNAJA1;AP2A1;PICALM
prerank,O-methyltransferase activity (GO:0008171),-0.2694796793201332,-0.585721110705575,0.9423503325942351,1.0,1.0,4/10,31.10%,FTSJ3;ASMT;BCDIN3D;MEPCE
prerank,histone methyltransferase activity (GO:0042054),-0.19982435949799657,-0.5842398368664323,0.9731182795698925,1.0,1.0,12/32,30.37%,KMT5A;EHMT2;SETDB1;DOT1L;CARM1;MEN1;PRMT8;FBL;PRMT2;SETD7;NTMT1;PRMT7
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.23790124193615905,-0.5811250100017061,0.9516908212560387,1.0,1.0,7/17,33.81%,ACOT11;PPT1;PLA2G6;ACOT9;ACOT8;ACOT1;ACOT7
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.25556081830453203,0.5792515285484537,0.949748743718593,1.0,1.0,7/20,19.17%,EIF3H;COPS2;YOD1;DESI2;USP7;USP25;USP21
prerank,acetyltransferase activity (GO:0016407),-0.1999536793675239,-0.5780066462173692,0.9895833333333334,1.0,1.0,6/31,15.56%,PAFAH2;ACAT1;SPHK1;SAT1;KAT8;PAFAH1B2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.26394862954597653,0.574884945377494,0.9459459459459459,1.0,1.0,2/14,11.89%,RDH16;ADH1A
prerank,glutathione transferase activity (GO:0004364),0.23623631409800722,0.5632564756852039,0.9622331691297209,1.0,1.0,4/23,12.62%,ALOX5AP;GSTA4;LTC4S;GSTP1
prerank,ATPase activator activity (GO:0001671),0.24895578554348421,0.561607480919794,0.956081081081081,1.0,1.0,5/20,20.03%,DNAJA1;ATP1B3;DNAJB1;DNAJC10;DNAJB6
prerank,four-way junction DNA binding (GO:0000400),-0.22579730159803435,-0.5569633326187431,0.9732360097323601,1.0,1.0,7/17,24.99%,RAD51B;MSH6;HMGB2;MEN1;RAD51C;GEN1;XRCC3
prerank,RNA polymerase core enzyme binding (GO:0043175),0.22155120589468727,0.5540539200046329,0.9730586370839936,1.0,1.0,8/33,18.93%,ZNF326;RRN3;RPRD1B;ESRRB;RPRD2;ERBB2;CDC73;RPRD1A
prerank,acetylcholine receptor activity (GO:0015464),-0.21064729363009985,-0.552411403760033,0.9776674937965261,1.0,1.0,14/22,47.85%,CHRNA7;CHRFAM7A;CHRM3;CHRM2;CHRM1;CHRNB2;CHRM5;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;HRH4
prerank,ribonuclease P activity (GO:0004526),0.26433251749414305,0.5502969348995249,0.9349736379613357,1.0,1.0,5/11,27.99%,RPP30;RPP25;PRORP;RPP38;RPP14
prerank,nucleotidase activity (GO:0008252),0.2515389392361934,0.5495034534744001,0.9426086956521739,1.0,1.0,2/15,10.88%,NT5C2;NT5C3A
prerank,neuropeptide receptor binding (GO:0071855),-0.2289495058327503,-0.5488633529268439,0.9711751662971175,1.0,1.0,4/14,30.80%,SHANK1;NPY;NTS;APLN
prerank,single-stranded DNA binding (GO:0003697),0.18619799963967346,0.5475193310796415,0.9946666666666667,1.0,1.0,12/93,13.02%,SAMHD1;MCM10;RPA1;POLA1;SUB1;RAD51D;MEIOB;RAD23A;LONP1;MCM9;ERCC4;TOP1
prerank,calcium-release channel activity (GO:0015278),0.2411455631842812,0.5472558808832727,0.9565972222222222,1.0,1.0,2/17,8.09%,ITPR3;PKD2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.22112592579312879,0.540290814099665,0.9621087314662273,1.0,1.0,9/27,26.10%,POLR1A;PRIMPOL;POLR1B;POLR3B;POLR3A;POLR2L;POLR2J;POLR3F;PRIM1
prerank,ribonuclease P RNA binding (GO:0033204),0.26746899131800334,0.5386358685488116,0.9353049907578558,1.0,1.0,2/10,12.20%,RPP30;RPP25
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.17599588930470905,-0.5359078532130466,0.9971830985915493,1.0,1.0,19/40,34.86%,DNMT3A;HNMT;TARBP1;LCMT1;TPMT;ASMT;NNMT;PRMT8;FBL;THUMPD3;RRP8;AS3MT;METTL18;PRMT7;GNMT;MEPCE;COMTD1;METTL2A;METTL2B
prerank,C-C chemokine receptor activity (GO:0016493),0.23366369735193188,0.5340594377515692,0.975328947368421,1.0,1.0,4/21,20.77%,CX3CR1;CXCR4;CCR1;CXCR6
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.22109910059571697,-0.5295742165692706,0.971830985915493,1.0,1.0,3/14,22.40%,ACO2;NFU1;RSAD2
prerank,tRNA binding (GO:0000049),0.201713383698603,0.5281256273728856,0.9955423476968797,1.0,1.0,19/43,32.42%,FARS2;EIF2AK4;AIMP1;KARS1;XPOT;YRDC;TRNAU1AP;NSUN6;ALKBH8;AARS2;TRMT10C;NSUN2;CARS1;RPUSD4;TRMT10A;NEMF;ALKBH1;TYW5;EIF2A
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.265658143912797,0.5239939143839026,0.9395085066162571,1.0,1.0,4/10,28.46%,SETD5;PRDM9;NSD2;SMYD2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.21023519233926613,-0.5183161383128713,0.9839816933638444,1.0,1.0,6/15,31.83%,KMT2D;SETMAR;SETD4;SETD1A;WDR5;WDR82
prerank,ATP hydrolysis activity (GO:0140603),0.20263552987413333,0.5176632693611972,0.9846860643185299,1.0,1.0,6/41,13.50%,KIF26A;SMCHD1;ABCA3;MYO1E;ABCD1;TOR3A
prerank,chemokine receptor binding (GO:0042379),0.2022967302029442,0.5146793390626002,0.9908536585365854,1.0,1.0,3/35,10.41%,CX3CR1;PPBP;CCL14
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.18935579000031677,0.5124625766616224,0.9971139971139971,1.0,1.0,13/57,24.79%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;UQCRQ;NDUFS4;NDUFS6;UQCRC1;NDUFB9;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,neuropeptide hormone activity (GO:0005184),0.22203379184724564,0.511791218271762,0.9761499148211243,1.0,1.0,22/22,77.83%,UCN;AGRP;PPY;NPFF;SPX;GAL;PNOC;OXT;CORT;NMB;QRFP;HCRT;GHRH;NPPA;CALCB;CRH;PENK;VIP;GRP;ADCYAP1;NPY;CCK
prerank,palmitoyltransferase activity (GO:0016409),0.20973525529873088,0.5114638983068684,0.9822294022617124,1.0,1.0,9/28,23.64%,ZDHHC18;ZDHHC9;HHAT;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC17;ZDHHC2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.18909421998719875,-0.5096839072540933,0.9922077922077922,1.0,1.0,2/24,8.44%,GLUL;ZDHHC20
prerank,damaged DNA binding (GO:0003684),-0.16252265250256542,-0.5070837777682794,1.0,1.0,1.0,17/44,32.50%,CRY2;DDB2;ERCC5;APTX;DDB1;XPC;HMGB2;NEIL3;SMC6;TDG;NTHL1;POLD1;RAD1;DCLRE1B;RPA2;ERCC1;FEN1
prerank,vitamin D receptor binding (GO:0042809),0.23923536731853517,0.5021949579097977,0.9637023593466425,1.0,1.0,4/14,22.79%,SNW1;TAF7;MED12;MED17
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.21903557540241847,-0.4972763046020872,0.9892008639308856,0.9984142439451451,1.0,3/11,21.58%,NAA40;NAA80;NAA60
prerank,chemokine activity (GO:0008009),-0.1646850859320196,-0.48657928230919417,1.0,0.9967189012001924,1.0,12/31,39.20%,CXCL16;CXCL12;CCL19;CCL2;CCL28;CCL5;CXCL5;CCL11;CCL4;PF4;CCL7;CCL8
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.22627886590266233,0.4700808878356101,0.9659735349716446,1.0,1.0,1/11,7.75%,ITPR3
prerank,deoxyribonuclease activity (GO:0004536),-0.19631019069029407,-0.46876393676215533,0.9926289926289926,0.9959108893062207,1.0,6/14,36.99%,ERCC5;MAP1S;DNASE1L2;DNASE1L1;ZRANB3;APLF
prerank,single-stranded DNA helicase activity (GO:0017116),0.20528761617684027,0.46392474183615445,0.9731543624161074,1.0,1.0,19/19,79.50%,HELB;RFC3;RFC5;MCM6;RFC2;MCM7;MCM2;RAD51;RFC4;MCM5;WRNIP1;POLQ;PIF1;CHTF8;CHTF18;DHX9;DSCC1;HELQ;DNA2
prerank,chemokine receptor activity (GO:0004950),0.19557046366090675,0.4612554940679794,0.9935691318327974,1.0,1.0,4/24,20.77%,CX3CR1;CXCR4;CCR1;CXCR6
prerank,N-methyltransferase activity (GO:0008170),0.2024659660735235,0.46114438911139877,0.9793459552495697,1.0,1.0,3/20,12.86%,TFB2M;PEMT;RNMT
prerank,pseudouridine synthase activity (GO:0009982),0.21747808751677278,0.4543352333795861,0.980836236933798,1.0,1.0,7/13,30.36%,PUS7L;TRUB1;RPUSD2;PUS7;PUSL1;RPUSD4;RPUSD1
prerank,beta-tubulin binding (GO:0048487),0.17962719270920863,0.44229303007271453,0.9967948717948718,1.0,1.0,9/31,22.69%,TTLL7;TRPV4;ARL8B;GABARAPL1;PEX14;RACGAP1;UXT;TAOK1;APPL1
prerank,single-stranded RNA binding (GO:0003727),0.17034811342310074,0.44095071924092083,0.9969230769230769,1.0,1.0,7/43,15.60%,HNRNPF;CNBP;LONP1;IFIH1;FMR1;ENDOV;AQR
prerank,proton transmembrane transporter activity (GO:0015078),0.1723532740453815,0.4381933171884252,0.9968798751950078,1.0,1.0,2/39,6.36%,CLCN3;OTOP2
prerank,endodeoxyribonuclease activity (GO:0004520),0.18871701986723247,0.42140747214149643,0.9868421052631579,1.0,1.0,9/20,28.28%,ERCC4;ENDOV;DCLRE1C;ENDOG;RPS3;MBD4;APEX1;RBBP8;EXOG
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.19279301902190984,0.4162335873877938,0.9929078014184397,1.0,1.0,14/14,80.74%,CAPN5;CAPN12;CAPN3;CAPN10;CAPN13;CAPN9;CAPNS2;CAPN11;CAPN8;CAPN15;CAPNS1;CAPN1;CAPN6;CAPN2
prerank,MHC protein binding (GO:0042287),0.1810814532400317,0.41048967012557025,0.9901477832512315,1.0,1.0,1/20,5.78%,TAP2
prerank,nuclear import signal receptor activity (GO:0061608),-0.1653983162382036,-0.4022314107996359,0.9978213507625272,0.9982776853334993,1.0,8/15,41.62%,TNPO2;KPNA2;IPO5;KPNA3;IPO9;IPO4;KPNA6;KPNA7
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.18447150389153907,0.38264330567603677,0.9962264150943396,1.0,1.0,11/11,81.57%,CHRNB1;CHRNA9;CHRNA4;CHRNA10;CHRNA2;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNB2;CHRNA7
prerank,ferrous iron binding (GO:0008198),0.15385617669352492,0.3486757546128053,0.9966777408637874,0.9994121552463415,1.0,5/21,23.67%,EGLN1;TET2;ACP5;EGLN2;FXN
